Gerrit A. Meijer - Publications

Affiliations: 
Pathology VU University Medical Center, Amsterdam, Netherlands 

339 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 van Toledo DE, Bleijenberg AG, Venema A, de Wit MJ, van Eeden S, Meijer GA, Carvalho B, Dekker E, Henneman P, IJspeert JE, van Noesel CJ. Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite-instable colorectal cancers. The Journal of Pathology. Clinical Research. 10: e348. PMID 38380944 DOI: 10.1002/cjp2.348  0.302
2022 Ykema BLM, Breekveldt ECH, Carvalho B, van Wezel T, Meijer GA, Kerst M, Schaapveld M, van Leeuwen FE, Snaebjornsson P, van Leerdam ME. Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors. British Journal of Cancer. PMID 36088508 DOI: 10.1038/s41416-022-01972-7  0.314
2020 Erve IV', Greuter MJE, Bolhuis K, Vessies DCL, Leal A, Vink GR, van den Broek D, Velculescu VE, Punt CJA, Meijer GA, Coupé VMH, Fijneman RJA. Diagnostic strategies towards clinical implementation of liquid biopsy RAS/BRAF circulating tumor DNA analyses in patients with metastatic colorectal cancer. The Journal of Molecular Diagnostics : Jmd. PMID 32961317 DOI: 10.1016/J.Jmoldx.2020.09.002  0.338
2020 Samsom KG, Levy S, van Veenendaal LM, Roepman P, Kodach LL, Steeghs N, Valk GD, Dercksen MW, Kuhlmann KFD, Verbeek WHM, Meijer GA, Tesselaar MET, van den Berg JG. Driver mutations occur frequently in metastases of well-differentiated small intestinal neuroendocrine tumours. Histopathology. PMID 32931025 DOI: 10.1111/His.14252  0.31
2020 Schraa SJ, van Rooijen KL, van der Kruijssen DEW, Rubio Alarcón C, Phallen J, Sausen M, Simmons J, Coupé VMH, van Grevenstein WMU, Elias S, Verkooijen HM, Laclé MM, Bosch LJW, van den Broek D, Meijer GA, et al. Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study. Bmc Cancer. 20: 790. PMID 32819390 DOI: 10.1186/S12885-020-07252-Y  0.364
2020 Greuter MJ, Carvalho B, Wit M, Dekker E, Spaander MC, Meijer GA, Engeland MV, Coupé VM. Can a biomarker triage test reduce colonoscopy burden in fecal immunochemical test screening? Journal of Comparative Effectiveness Research. 9: 563-571. PMID 32462913 DOI: 10.2217/Cer-2019-0130  0.337
2020 Jongeneel G, Greuter MJE, van Erning FN, Koopman M, Medema JP, Kandimalla R, Goel A, Bujanda L, Meijer GA, Fijneman RJA, van Oijen MGH, Ijzermans J, Punt CJA, Vink GR, Coupé VMH. Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN). The European Journal of Health Economics : Hepac : Health Economics in Prevention and Care. PMID 32458162 DOI: 10.1007/S10198-020-01199-4  0.351
2020 Vessies DCL, Greuter MJE, van Rooijen KL, Linders TC, Lanfermeijer M, Ramkisoensing KL, Meijer GA, Koopman M, Coupé VMH, Vink GR, Fijneman RJA, van den Broek D. Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing. Scientific Reports. 10: 8122. PMID 32415199 DOI: 10.1038/S41598-020-64822-7  0.309
2020 Leal A, van Grieken NCT, Palsgrove DN, Phallen J, Medina JE, Hruban C, Broeckaert MAM, Anagnostou V, Adleff V, Bruhm DC, Canzoniero JV, Fiksel J, Nordsmark M, Warmerdam FARM, Verheul HMW, ... ... Meijer GA, et al. White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer. Nature Communications. 11: 525. PMID 31988276 DOI: 10.1038/S41467-020-14310-3  0.391
2020 Ykema B, Rigter L, Spaander M, Moons L, Bisseling T, Aleman B, de Boer JP, Lugtenburg P, Janus C, Petersen E, Roesink J, Raemaekers J, van der Maazen R, Lansdorp-Vogelaar I, Gini A, ... ... Meijer G, et al. Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors. Journal of Clinical Medicine. 9. PMID 31936745 DOI: 10.3390/Jcm9010190  0.384
2020 Erve Iv', Rovers KP, Constantinides A, Bolhuis K, Wassenaar EC, Lurvink RJ, Huysentruyt CJ, Snaebjornsson P, Broek Dvd, Buffart TE, Kok NF, Meijer GA, Punt CJ, Kranenburg O, Hingh IHd, et al. Abstract 708: Limited release of circulating tumor DNA into the systemic circulation by peritoneal metastases from colorectal cancer Clinical Trials. DOI: 10.1158/1538-7445.Am2020-708  0.354
2020 Alarcón CR, Kruijssen DEvd, Meiqari L, Bosch LJ, Simmons JK, Velculescu VE, Broek Dvd, Punt CJ, Coupé VM, Koopman M, Meijer GA, Vink GR, Fijneman RJ. Abstract 3096: Liquid biopsy cell-free circulating tumor DNA as prognostic biomarker for stage III colon cancer patients Clinical Trials. DOI: 10.1158/1538-7445.Am2020-3096  0.383
2019 Komor MA, Bosch LJ, Coupe VM, Rausch C, Pham TV, Piersma SR, Mongera S, Mulder CJ, Dekker E, Kuipers EJ, van de Wiel MA, Carvalho B, Fijneman RJ, Jimenez CR, Meijer GA, et al. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression. The Journal of Pathology. PMID 31784980 DOI: 10.1002/Path.5369  0.378
2019 Bosch LJW, Melotte V, Mongera S, Daenen KLJ, Coupé VMH, van Turenhout ST, Stoop EM, de Wijkerslooth TR, Mulder CJJ, Rausch C, Kuipers EJ, Dekker E, Domanico MJ, Lidgard GP, Berger BM, ... ... Meijer GA, et al. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population. The American Journal of Gastroenterology. 114: 1909-1918. PMID 31764091 DOI: 10.14309/Ajg.0000000000000445  0.381
2019 den Uil SH, van den Broek E, Coupé VMH, Vellinga TT, Delis-van Diemen PM, Bril H, Belt EJT, Kranenburg O, Stockmann HBAC, Belien JAM, Meijer GA, Fijneman RJA. Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study. Bmc Gastroenterology. 19: 146. PMID 31420015 DOI: 10.1186/S12876-019-1063-4  0.378
2019 Komor MA, de Wit M, van den Berg J, Martens de Kemp SR, Delis-van Diemen PM, Bolijn AS, Tijssen M, Schelfhorst T, Piersma SR, Chiasserini D, Sanders J, Rausch C, Hoogstrate Y, Stubbs AP, de Jong M, ... ... Meijer GA, et al. Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression. International Journal of Cancer. PMID 31411736 DOI: 10.1002/Ijc.32627  0.426
2019 Wanders LK, Cordes M, Voorham Q, Sie D, de Vries SD, d'haens GRAM, de Boer NKH, Ylstra B, van Grieken NCT, Meijer GA, Dekker E, Carvalho B. IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas. Inflammatory Bowel Diseases. PMID 31372648 DOI: 10.1093/Ibd/Izz171  0.4
2019 Ried T, Meijer GA, Harrison DJ, Grech G, Franch-Expósito S, Briffa R, Carvalho B, Camps J. The landscape of genomic copy number alterations in colorectal cancer and their consequences on gene expression levels and disease outcome. Molecular Aspects of Medicine. PMID 31365882 DOI: 10.1016/J.Mam.2019.07.007  0.421
2019 Cristiano S, Leal A, Phallen J, Fiksel J, Adleff V, Bruhm DC, Jensen SØ, Medina JE, Hruban C, White JR, Palsgrove DN, Niknafs N, Anagnostou V, Forde P, Naidoo J, ... ... Meijer GA, et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature. PMID 31142840 DOI: 10.1038/S41586-019-1272-6  0.421
2019 Vleugels JLA, van Neerven SM, van Leerdam ME, Wanders LK, de Wit M, Carvalho B, Delis-van Diemen PM, Kallenberg FGJ, Vermeulen L, Beliën JA, East JE, Meijer GA, Dekker E. CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients. Endoscopy International Open. 7: E701-E707. PMID 31073537 DOI: 10.1055/A-0832-8283  0.321
2019 Hummelink K, Muller M, Linders TC, Noort Vvd, Nederlof PM, Baas P, Burgers S, Smit EF, Meijer GA, Heuvel MMvd, Broek Dvd, Monkhorst K. Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions Erj Open Research. 5. PMID 30918895 DOI: 10.1183/23120541.00016-2019  0.323
2019 Lanschot MCJv, Carvalho B, Rausch C, Snaebjornsson P, Engeland Mv, Kuipers EJ, Stoker J, Nolthenius CJT, Dekker E, Meijer GA. Molecular profiling of longitudinally observed small colorectal polyps : A cohort study Ebiomedicine. 39: 292-300. PMID 30555044 DOI: 10.1016/J.Ebiom.2018.12.009  0.398
2019 Leal A, Cristiano S, Phallen J, Fiksel J, Adleff V, Bruhm DC, Jensen SØ, Medina JE, Palsgrove DN, Niknafs N, Anagnostou V, Forde PM, Brahmer JR, Fijneman R, Johansen JS, ... ... Meijer GA, et al. Genome-wide cell-free DNA fragmentation profiling for early cancer detection. Journal of Clinical Oncology. 37: 3018-3018. DOI: 10.1200/Jco.2019.37.15_Suppl.3018  0.376
2019 Kemp SRM, Komor MA, Hegi R, Tijssen M, Bolijn AS, Meijer GA, Jimenez CR, Fijneman RJ, Carvalho B. Abstract 4638: Colorectal adenoma-to-carcinoma progression: The role of miR-17-92 cluster Cancer Research. 79: 4638-4638. DOI: 10.1158/1538-7445.Am2019-4638  0.34
2019 Fijneman RJA, Mekkes N, Broek Evd, Stringer B, Glas RA, Komor MA, Rausch C, Lieshout Sv, Cuppen E, Smith ML, Sebra RP, Rowell WJ, Ashby M, Carvalho B, Heringa J, ... Meijer GA, et al. Abstract 1738: Characterization of structural variants within MACROD2 in the pathogenesis of colorectal cancer Cancer Research. DOI: 10.1158/1538-7445.Am2019-1738  0.378
2019 Vessies DC, Linders TC, Ramkisoensing KL, Nederlof PM, Meijer GA, Monkhorst K, Broek Dvd. Abstract 1381: Technical validation of Roche AVENIO sequencing platform for liquid biopsies Cancer Research. 79: 1381-1381. DOI: 10.1158/1538-7445.Am2019-1381  0.322
2019 Roepman P, Bosch L, Samsom K, Schipper L, Bruijn Ed, Hoes L, Riethorst I, Schoenmaker L, Kolk Lvd, Snellenberg Hv, Voest EE, Cuppen E, Monkhorst K, Meijer G. WGS implementation in standard cancer diagnostics for every cancer patient (WIDE) Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz257.003  0.409
2018 Rigter LS, Spaander MCW, Aleman BMP, Bisseling TM, Moons LM, Cats A, Lugtenburg PJ, Janus CPM, Petersen EJ, Roesink JM, van der Maazen RWM, Snaebjornsson P, Kuipers EJ, Bruno MJ, Dekker E, ... Meijer GA, et al. High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors. Cancer. PMID 30561773 DOI: 10.1002/Cncr.31903  0.383
2018 Neerincx M, Poel D, Sie DLS, van Grieken NCT, Shankaraiah RC, van der Wolf-de Lijster FSW, van Waesberghe JTM, Burggraaf JD, Eijk PP, Verhoef C, Ylstra B, Meijer GA, van de Wiel MA, Buffart TE, Verheul HMW. Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer. Plos One. 13: e0201809. PMID 30075027 DOI: 10.1371/Journal.Pone.0201809  0.352
2018 Broek Evd, Uil SHd, Coupé VMH, Diemen PMD, Bolijn AS, Bril H, Stockmann HBAC, Grieken NCTv, Meijer GA, Fijneman RJA. MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer. Oncotarget. 9: 29445-29452. PMID 30034629 DOI: 10.18632/Oncotarget.25655  0.421
2018 Komor MA, Bosch LJ, Bounova G, Bolijn AS, van-Diemen PD, Rausch C, Hoogstrate Y, Stubbs AP, de Jong M, Jenster G, van Grieken NC, Carvalho B, Wessels LF, Jimenez CR, Fijneman RJ, ... Meijer GA, et al. Consensus molecular subtypes classification of colorectal adenomas. The Journal of Pathology. PMID 29968252 DOI: 10.1002/Path.5129  0.387
2018 Jacobsen A, Bosch LJW, Martens-de Kemp SR, Carvalho B, Sillars-Hardebol AH, Dobson RJ, de Rinaldis E, Meijer GA, Abeln S, Heringa J, Fijneman RJA, Feenstra KA. Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer. Scientific Reports. 8: 7522. PMID 29760449 DOI: 10.1038/S41598-018-24982-Z  0.313
2018 Carvalho B, Diosdado B, Terhaar Sive Droste JS, Bolijn AS, Komor MA, de Wit M, Bosch LJW, van Burink M, Dekker E, Kuipers EJ, Coupe VMH, van Grieken NCT, Fijneman RJA, Meijer GA. Evaluation of cancer associated DNA copy number events in colorectal (advanced) adenomas. Cancer Prevention Research (Philadelphia, Pa.). PMID 29685877 DOI: 10.1158/1940-6207.Capr-17-0317  0.399
2018 Rigter LS, Snaebjornsson P, Rosenberg EH, Atmodimedjo PN, Aleman BM, Ten Hoeve J, Geurts-Giele WR, van Ravesteyn TW, Hoeksel J, Meijer GA, Te Riele H, van Leeuwen FE, Dinjens WN, van Leerdam ME. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment. Gut. 67: 447-455. PMID 29439113 DOI: 10.1136/Gutjnl-2016-312608  0.402
2018 Komor MA, Bosch LJ, Bounova G, Bolijn AS, Diemen PD, Rausch C, Hoogstrate Y, Stubbs A, Jong Md, Jenster G, Grieken NCa, Carvalho B, Wessels L, Jimenez CR, Fijneman RJ, ... Meijer GA, et al. Abstract 3676: CMS classification of colorectal adenomas Cancer Research. 78: 3676-3676. DOI: 10.1158/1538-7445.Am2018-3676  0.423
2018 Dijk Ev, Biesma H, Cordes M, Smeets D, Neerincx M, Das S, Murphy V, Barat A, Bacon O, Prehn JHM, Betge J, Timo G, Fender B, Meijer GA, McNamara DA, et al. Abstract 2579: Loss of chromosome 18q11.2-18q12.1 is predictive for progression-free survival in metastatic colorectal cancer patients treated with bevacizumab Cancer Research. 78: 2579-2579. DOI: 10.1158/1538-7445.Am2018-2579  0.368
2018 Beintaris I, Rutter MD, Valori R, Chiu HM, Corley DA, Cuatrecasas M, Dekker E, Forsberg A, Gore-Booth J, Haug U, Kaminski MF, Matsuda T, Meijer GA, Morris E, Plumb AA, et al. PTU-031 The world endoscopy organisation consensus statements on post-colonoscopy and post-imaging colorectal cancer Gut. DOI: 10.1136/Gutjnl-2018-Bsgabstracts.372  0.361
2017 Bosch LJW, de Wit M, Pham TV, Coupé VMH, Hiemstra AC, Piersma SR, Oudgenoeg G, Scheffer GL, Mongera S, Sive Droste JT, Oort FA, van Turenhout ST, Ben Larbi I, Louwagie J, van Criekinge W, ... ... Meijer GA, et al. Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study. Annals of Internal Medicine. PMID 29159365 DOI: 10.7326/M17-1068  0.398
2017 Greuter MJE, de Klerk CM, Meijer GA, Dekker E, Coupé VMH. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis. Annals of Internal Medicine. PMID 28973514 DOI: 10.7326/M16-2891  0.375
2017 Bosch LJW, Trooskens G, Snaebjornsson P, Coupé VMH, Mongera S, Haan JC, Richman SD, Koopman M, Tol J, de Meyer T, Louwagie J, Dehaspe L, van Grieken NCT, Ylstra B, Verheul HMW, ... ... Meijer GA, et al. Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer. Oncotarget. 8: 63140-63154. PMID 28968978 DOI: 10.18632/Oncotarget.18702  0.351
2017 Phallen J, Sausen M, Adleff V, Leal A, Hruban C, White J, Anagnostou V, Fiksel J, Cristiano S, Papp E, Speir S, Reinert T, Orntoft MW, Woodward BD, Murphy D, ... ... Meijer G, et al. Direct detection of early-stage cancers using circulating tumor DNA. Science Translational Medicine. 9. PMID 28814544 DOI: 10.1126/Scitranslmed.Aan2415  0.428
2017 Komor MA, Pham T, Hiemstra AC, Piersma SR, Bolijn AS, Schelfhorst T, Delis-van Diemen PM, Tijssen M, Sebra RP, Ashby M, Meijer GA, Jimenez CR, Fijneman RJA. Identification of differentially expressed splice variants by the proteogenomic pipeline Splicify. Molecular & Cellular Proteomics : McP. PMID 28747380 DOI: 10.1074/Mcp.Tir117.000056  0.331
2017 Lansdorp-Vogelaar I, Goede SL, Bosch LJW, Melotte V, Carvalho B, van Engeland M, Meijer GA, de Koning HJ, van Ballegooijen M. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Non-Invasive Colorectal Cancer Screening. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 28733262 DOI: 10.1016/J.Cgh.2017.07.011  0.366
2017 Coebergh van den Braak RRJ, van Rijssen LB, van Kleef JJ, Vink GR, Berbee M, van Berge Henegouwen MI, Bloemendal HJ, Bruno MJ, Burgmans MC, Busch ORC, Coene PPLO, Coupé VMH, Dekker JWT, van Eijck CHJ, Elferink MAG, ... ... Meijer GA, et al. Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative. Acta Oncologica (Stockholm, Sweden). 1-8. PMID 28723307 DOI: 10.1080/0284186X.2017.1346381  0.393
2017 Lanschot MCJv, Bosch LJW, Wit Md, Carvalho B, Meijer GA. Early detection: the impact of genomics Virchows Archiv. 471: 165-173. PMID 28573511 DOI: 10.1007/S00428-017-2159-2  0.411
2017 de Wit M, Carvalho B, Delis-van Diemen PM, van Alphen C, Beliën JAM, Meijer GA, Fijneman RJA. Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression. Plos One. 12: e0174768. PMID 28481899 DOI: 10.1371/Journal.Pone.0174768  0.415
2017 Snaebjornsson P, Jonasson L, Olafsdottir EJ, van Grieken NCT, Moller PH, Theodors A, Jonsson T, Meijer GA, Jonasson JG. Why is colon cancer survival improving by time? A nationwide survival analysis spanning 35 years. International Journal of Cancer. PMID 28477390 DOI: 10.1002/Ijc.30766  0.334
2017 Abou-El-Ardat K, Seifert M, Becker K, Eisenreich S, Lehmann M, Hackmann K, Rump A, Meijer G, Carvalho B, Temme A, Schackert G, Schröck E, Krex D, Klink B. Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas. Neuro-Oncology. PMID 28201779 DOI: 10.1093/Neuonc/Now231  0.328
2017 van Lanschot MC, Carvalho B, Coupé VM, van Engeland M, Dekker E, Meijer GA. Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study. Bmc Cancer. 17: 116. PMID 28173852 DOI: 10.1186/S12885-017-3078-Y  0.388
2017 Rigter LS, Spaander MC, Moons LM, Bisseling TM, Aleman BM, de Boer JP, Lugtenburg PJ, Janus CP, Petersen EJ, Roesink JM, Raemaekers JM, van der Maazen RW, Cats A, Bleiker EM, Snaebjornsson P, ... ... Meijer GA, et al. Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design. Bmc Cancer. 17: 112. PMID 28173773 DOI: 10.1186/S12885-017-3089-8  0.427
2017 Toes-Zoutendijk E, Leerdam MEv, Dekker E, Hees Fv, Penning C, Nagtegaal I, Meulen MPvd, Vuuren AJv, Kuipers EJ, Bonfrer JMG, Biermann K, Thomeer MGJ, Veldhuizen Hv, Kroep S, Ballegooijen Mv, ... Meijer GA, et al. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels. Gastroenterology. 152: 767-775. PMID 27890769 DOI: 10.1053/J.Gastro.2016.11.022  0.31
2017 Broek Evd, Dijkstra MJJ, Voorham QJM, Carvalho B, Wiel MAvd, Abeln S, Meijer GA, Fijneman RJA. Abstract A07: Detection of structural variants and recurrent breakpoint genes in colorectal adenoma-to-carcinoma progression Cancer Research. 77. DOI: 10.1158/1538-7445.Crc16-A07  0.424
2017 Phallen JA, Sausen M, Adleff V, Leal A, Fiksel J, Hruban C, Speir S, Papp E, Anagnostou V, Orntoft MW, Reinert T, Woodward BD, Murphy D, Parpart-Li S, Riley D, ... ... Meijer G, et al. Abstract LB-246: Detection of circulating tumor DNA in early stage cancers Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-246  0.35
2017 Vink G, Braak RCvd, Bloemendal H, Coupé V, Elferink M, Erdkamp F, Grevenstein Hv, Groot Jd, Ijzermans J, Intven M, Los M, Noo Md, Oijen Mv, Punt C, Rietbroek R, ... ... Meijer G, et al. Abstract CT067: The Prospective Dutch ColoRectal Cancer Cohort (PLCRC): a prospective nationwide observational cohort study providing the infrastructure for registry based trials Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Ct067  0.408
2017 Lanschot MCv, Carvalho B, Nolthenius CJT, Rausch CR, Kuipers EJ, Stoker J, Dekker E, Meijer GA. Abstract 716: Genomic classification of longitudinally observed small colorectal polyps Cancer Research. 77: 716-716. DOI: 10.1158/1538-7445.Am2017-716  0.424
2017 Komor MA, Pham TV, Piersma SR, Bolijn AS, Schelfhorst T, Diemen PMD, Tijssen M, Hiemstra AC, Wit Md, Carvalho B, Meijer GA, Jimenez CR, Fijneman RJ. Abstract 1559: Proteogenomic analysis of alternative splicing in colorectal adenoma-to-carcinoma progression Cancer Research. 77: 1559-1559. DOI: 10.1158/1538-7445.Am2017-1559  0.405
2016 van den Broek E, van Lieshout S, Rausch C, Ylstra B, van de Wiel MA, Meijer GA, Fijneman RJA, Abeln S. GeneBreak: detection of recurrent DNA copy number aberration-associated chromosomal breakpoints within genes. F1000research. 5: 2340. PMID 28713543 DOI: 10.12688/F1000Research.9259.2  0.349
2016 den Uil SH, Coupé VM, Linnekamp JF, van den Broek E, Goos JA, Delis-van Diemen PM, Belt EJ, van Grieken NC, Scott PM, Vermeulen L, Medema JP, Bril H, Stockmann HB, Cormier RT, Meijer GA, et al. Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence. British Journal of Cancer. PMID 27855440 DOI: 10.1038/Bjc.2016.376  0.403
2016 van den Broek E, Krijgsman O, Sie D, Tijssen M, Mongera S, van de Wiel MA, Th Belt EJ, den Uil SH, Bril H, Stockmann HB, Ylstra B, Carvalho B, Meijer GA, Fijneman RJ. Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients. Oncotarget. PMID 27729614 DOI: 10.18632/Oncotarget.12510  0.42
2016 Burbach JPM, Kurk SA, Braak RRJCvd, Dik VK, May AM, Meijer GA, Punt CJA, Vink GR, Los M, Hoogerbrugge N, Huijgens PC, Ijzermans JNM, Kuipers EJ, Noo MEd, Pennings JP, et al. Prospective Dutch colorectal cancer cohort : an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research Acta Oncologica. 55: 1273-1280. PMID 27560599 DOI: 10.1080/0284186X.2016.1189094  0.374
2016 van der Meijde E, van den Eertwegh AJ, Linn SC, Meijer GA, Fijneman RJ, Coupé VM. The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care. Cancer Informatics. 15: 115-27. PMID 27346945 DOI: 10.4137/Cin.S38122  0.317
2016 Obulkasim A, Ylstra B, van Essen HF, Benner C, Stenning S, Langley R, Allum W, Cunningham D, Inam I, Hewitt LC, West NP, Meijer GA, van de Wiel MA, Grabsch HI. Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma. Oncotarget. PMID 27286451 DOI: 10.18632/Oncotarget.9857  0.339
2016 Greuter MJ, Berkhof J, Fijneman RJ, Demirel E, Lew JB, Meijer GA, Stoker J, Coupé VM. The Potential of Imaging Techniques as a Screening Tool for Colorectal Cancer: a Cost-Effectiveness Analysis. The British Journal of Radiology. 20150910. PMID 27194458 DOI: 10.1259/Bjr.20150910  0.31
2016 Bosch LJ, Luo Y, Valinluck Lao V, Snaebjornsson P, Trooskens G, Vlassenbroeck I, Mongera S, Tang W, Welcsh P, Herman JG, Koopman M, Nagtegaal I, Punt CJ, Van Criekinge W, Meijer GA, et al. WRN promoter CpG island hypermethylation does not predict more favorable outcomes for metastatic colorectal cancer patients treated with irinotecan-based therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27121793 DOI: 10.1158/1078-0432.Ccr-15-2703  0.376
2016 Sluiter N, Cuba Ed, Kwakman R, Kazemier G, Meijer G, Velde EAt. Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options Clinical & Experimental Metastasis. 33: 401-416. PMID 27074785 DOI: 10.1007/S10585-016-9791-0  0.354
2016 Sluiter NR, Cuba EMVd, Kwakman R, Meijerink WJHJ, Diemen PMD, Coupé VMH, Beliën JAM, Meijer GA, Hingh IHJTd, Velde EAt. Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Clinical & Experimental Metastasis. 33: 297-307. PMID 26873137 DOI: 10.1007/S10585-016-9779-9  0.362
2016 Young GP, Senore C, Mandel JS, Allison JE, Atkin WS, Benamouzig R, Bossuyt PM, Silva M, Guittet L, Halloran SP, Haug U, Hoff G, Itzkowitz SH, Leja M, Levin B, ... Meijer GA, et al. Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer. Cancer. PMID 26828588 DOI: 10.1002/Cncr.29865  0.348
2016 Than BL, Linnekamp JF, Starr TK, Largaespada DA, Rod A, Zhang Y, Bruner V, Abrahante J, Schumann A, Luczak T, Niemczyk A, O'Sullivan MG, Medema JP, Fijneman RJ, Meijer GA, et al. CFTR is a tumor suppressor gene in murine and human intestinal cancer. Oncogene. PMID 26751771 DOI: 10.1038/Onc.2015.483  0.342
2016 de Cuba EM, de Hingh IH, Sluiter NR, Kwakman R, Coupé VM, Beliën JA, Verwaal VJ, Meijerink WJ, Delis-van Diemen PM, Bonjer HJ, Meijer GA, Te Velde EA. Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer. Annals of Surgical Oncology. PMID 26727921 DOI: 10.1245/S10434-015-5023-0  0.367
2016 Goos JA, Coupé VM, van de Wiel MA, Diosdado B, Delis-Van Diemen PM, Hiemstra AC, de Cuba EM, Beliën JA, Menke-van der Houven van Oordt CW, Geldof AA, Meijer GA, Hoekstra OS, Fijneman RJ. A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9. Oncotarget. 7: 2123-34. PMID 26497206 DOI: 10.18632/Oncotarget.6188  0.394
2016 Goos JA, Verbeek J, Geldof AA, Hiemstra AC, van de Wiel MA, Adamzek KA, Delis-Van Diemen PM, Stroud SG, Bradley DP, Meijer GA, Hoekstra OS, Fijneman RJ, Windhorst AD. Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237). Nuclear Medicine and Biology. 43: 63-72. PMID 26432753 DOI: 10.1016/J.Nucmedbio.2015.08.007  0.333
2016 Komor MA, Hiemstra AC, Pham TV, Piersma SR, Sebra RP, Han BW, Ashby M, Carvalho B, Meijer GA, Jimenez CR, Fijneman RJ. Abstract 848: Proteogenomic analysis of alternative splicing: the search for novel biomarkers for colorectal cancer Cancer Research. 76: 848-848. DOI: 10.1158/1538-7445.Am2016-848  0.357
2016 Bosch LJW, Melotte V, Mongera S, Daenen KLJ, Coupe VHM, Turenhout STv, Stoop EM, Wijkerslooth TRd, Mulder CJJ, Kuipers EJ, Dekker E, Domanico M, Lidgard GP, Berger BM, Carvalho B, ... ... Meijer GA, et al. Abstract 4338: Advanced neoplasia detection in colorectal cancer screening using multiple stool DNA markers and haemoglobin Cancer Research. 76: 4338-4338. DOI: 10.1158/1538-7445.Am2016-4338  0.414
2016 Bosch LJ, Wit MD, Hiemstra AC, Piersma SR, Pham TV, Oudgenoeg G, Coupe V, Scheffer G, Mongera S, droste JTS, Oort F, Turenhout Sv, Larbi IB, Mulder C, Carvalho B, ... ... Meijer GA, et al. Abstract 3176: Improved colorectal cancer screening by new stool-based protein markers Cancer Research. 76: 3176-3176. DOI: 10.1158/1538-7445.Am2016-3176  0.389
2016 Bierkens M, Linden Wvd, Weistra W, Bochove Kv, Beliën JAM, Fijneman RJA, Azevedo R, Boiten J, Meijer GA. Abstract 3166: Querying, viewing and analyzing colorectal cancer translational research studies in tranSMART Cancer Research. 76: 3166-3166. DOI: 10.1158/1538-7445.Am2016-3166  0.326
2016 Uil SHd, Coupe VMH, Linnekamp JF, Broek Evd, Goos JACM, Diemen PMD, Belt EJT, Grieken NCTv, Scott PM, Vermeulen L, Medema JP, Bril H, Stockmann HBAC, Cormier RT, Meijer GA, et al. Abstract 3125: KCNQ1 expression is a strong prognostic biomarker for disease recurrence in stage II and III colon cancer Cancer Research. 76: 3125-3125. DOI: 10.1158/1538-7445.Am2016-3125  0.404
2016 Braak RRJCvd, Vink GR, Oijen MGHv, Noo MEd, Kurk SA, Burbach MJP, Couwenberg AM, May AM, Verkooijen HM, Meijer GA, Koopman M. Abstract 1827: The prospective Dutch colorectal cancer cohort: A prospective nation-wide observational cohort study Cancer Research. 76: 1827-1827. DOI: 10.1158/1538-7445.Am2016-1827  0.382
2016 Grieken NCv, Cordes M, Verheul HM, Neerincx M, Punt C, Koopman M, Meijer GA, Murphy V, Barat A, Betge J, Ebert M, Gaiser T, Fender B, Klinger R, Das S, et al. Copy number alterations as predictive biomarkers for response to bevacizumab in metastatic colorectal cancer Annals of Oncology. 27. DOI: 10.1093/Annonc/Mdw363.02  0.383
2016 Ylstra B, Cordes M, Biesma HD, Verheul HM, Neerincx M, Koopman M, Punt CJ, Meijer GA, Murphy V, Barat A, Betge J, Ebert M, Gaiser T, Fender B, Klinger R, et al. Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer European Journal of Cancer. 69. DOI: 10.1016/S0959-8049(16)32666-1  0.4
2016 IJspeert J, Bosch L, Bossuyt P, Coupé V, Engeland Mv, Carvalho B, Kuipers EJ, Meijer G, Dekker E. Mo1692 Detection of Advanced Colorectal Lesions in Asymptomatic Individuals; Comparison of FIT, Clinical Risk Factors and Stool DNA Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)32557-4  0.303
2015 IJspeert JE, Rana SA, Atkinson NS, van Herwaarden YJ, Bastiaansen BA, van Leerdam ME, Sanduleanu S, Bisseling TM, Spaander MC, Clark SK, Meijer GA, van Lelyveld N, Koornstra JJ, Nagtegaal ID, East JE, et al. Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis. Gut. PMID 26603485 DOI: 10.1136/Gutjnl-2015-310630  0.354
2015 Greuter MJ, Demirel E, Lew JB, Berkhof J, Xu XM, Canfell K, Dekker E, Meijer GA, Coupe VM. Long-term Impact of the Dutch Colorectal Cancer Screening Programme on Cancer Incidence and Mortality - Model-based Exploration of the Serrated Pathway. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26598535 DOI: 10.1158/1055-9965.Epi-15-0592  0.379
2015 de Cuba EM, Snaebjornsson P, Heideman DA, van Grieken NC, Bosch LJ, Fijneman RJ, Belt E, Bril H, Stockmann HB, Hooijberg E, Punt CJ, Koopman M, Nagtegaal ID, Coupé VH, Carvalho B, ... Meijer GA, et al. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers. International Journal of Cancer. Journal International Du Cancer. PMID 26376292 DOI: 10.1002/Ijc.29855  0.378
2015 van den Broek E, Dijkstra MJ, Krijgsman O, Sie D, Haan JC, Traets JJ, van de Wiel MA, Nagtegaal ID, Punt CJ, Carvalho B, Ylstra B, Abeln S, Meijer GA, Fijneman RJ. High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer. Plos One. 10: e0138141. PMID 26375816 DOI: 10.1371/Journal.Pone.0138141  0.399
2015 Hugen N, Simmer F, Mekenkamp LJ, Koopman M, den Broek EV, de Wilt JH, Punt CJ, Ylstra B, Meijer GA, Nagtegaal ID. Reduced rate of copy number aberrations in mucinous colorectal carcinoma. Oncotarget. PMID 26329972 DOI: 10.18632/Oncotarget.4706  0.375
2015 Lenos K, Goos JA, Vuist IM, den Uil SH, Delis-van Diemen PM, Belt EJ, Stockmann HB, Bril H, de Wit M, Carvalho B, Giblett S, Pritchard CA, Meijer GA, van Kooyk Y, Fijneman RJ, et al. MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients. Oncotarget. PMID 26172302 DOI: 10.18632/Oncotarget.4495  0.385
2015 IJspeert JE, Vermeulen L, Meijer GA, Dekker E. Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nature Reviews. Gastroenterology & Hepatology. PMID 25963511 DOI: 10.1038/Nrgastro.2015.73  0.363
2015 Huiskens J, van Gulik TM, van Lienden KP, Engelbrecht MR, Meijer GA, van Grieken NC, Schriek J, Keijser A, Mol L, Molenaar IQ, Verhoef C, de Jong KP, Dejong KH, Kazemier G, Ruers TM, et al. Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG). Bmc Cancer. 15: 365. PMID 25943574 DOI: 10.1186/S12885-015-1323-9  0.388
2015 Hubers AJ, Heideman DA, Burgers SA, Herder GJ, Sterk PJ, Rhodius RJ, Smit HJ, Krouwels F, Welling A, Witte BI, Duin S, Koning R, Comans EF, Steenbergen RD, Postmus PE, ... Meijer GA, et al. DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach. British Journal of Cancer. 112: 1105-13. PMID 25719833 DOI: 10.1038/Bjc.2014.636  0.302
2015 Goos JA, de Cuba EM, Coupé VM, Diosdado B, Delis-Van Diemen PM, Karga C, Beliën JA, Menke-Van der Houven van Oordt CW, Geldof AA, Meijer GA, Hoekstra OS, Fijneman RJ. Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis. Annals of Surgery. PMID 25563886 DOI: 10.1097/Sla.0000000000001109  0.382
2015 Melotte V, Yi JM, Lentjes MH, Smits KM, Van Neste L, Niessen HE, Wouters KA, Louwagie J, Schuebel KE, Herman JG, Baylin SB, van Criekinge W, Meijer GA, Ahuja N, van Engeland M. Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in blood. Cancer Prevention Research (Philadelphia, Pa.). 8: 157-64. PMID 25538088 DOI: 10.1158/1940-6207.Capr-14-0198  0.367
2015 Sanduleanu S, le Clercq CM, Dekker E, Meijer GA, Rabeneck L, Rutter MD, Valori R, Young GP, Schoen RE. Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature. Gut. 64: 1257-67. PMID 25193802 DOI: 10.1136/Gutjnl-2014-307992  0.4
2015 Duits LC, Phoa KN, Curvers WL, Ten Kate FJ, Meijer GA, Seldenrijk CA, Offerhaus GJ, Visser M, Meijer SL, Krishnadath KK, Tijssen JG, Mallant-Hent RC, Bergman JJ. Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel. Gut. 64: 700-6. PMID 25034523 DOI: 10.1136/Gutjnl-2014-307278  0.311
2015 Huiskens J, Gulik TMv, Lienden KPv, Engelbrecht MRW, Meijer GA, Grieken NCTv, Schriek J, Keijser A, Mol L, Molenaar IQ, Verhoef C, Jong KPd, Dejong CHC, Kazemier G, Ruers T, et al. Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases: The randomized phase III CAIRO5 study of the Dutch Colorectal Cancer Group. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.Tps3622  0.391
2015 Buffart TE, Neerincx M, Sie DL, Wiel MAvd, Grieken NCTv, Burggraaf JD, Dekker H, Eijk PP, Ylstra B, Verhoef C, Meijer GA, Verheul HMW. Comparison of deep sequencing miRNA expression analysis in primary colorectal cancer and paired metastases. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E14682  0.324
2015 Goos JACM, Cuba EMVd, Coupe VMH, Diosdado B, Diemen PMD, Karga C, Belien JAM, Oordt CWMVdHv, Geldof AA, Meijer GA, Hoekstra OS, Fijneman RJA. Abstract 3419: VEGFA and SLC2A1 are prognostic biomarkers for patients with resectable colorectal cancer liver metastases Cancer Research. 75: 3419-3419. DOI: 10.1158/1538-7445.Am2015-3419  0.386
2015 Vries Sd, Clercq Cl, Grieken Nv, Heideman D, Engeland Mv, Broek Evd, Cordes M, Ylstra B, Nagtegaal ID, Punt CJ, Meijer GA, Masclee A, Sanduleanu S, Carvalho B. Su1998 Genomic Profile and Clinicopathological Analysis of Postcolonoscopy Colorectal Cancers: A Pilot Study Gastroenterology. 148. DOI: 10.1016/S0016-5085(15)31927-2  0.349
2014 Greuter MJ, Demirel E, Berkhof J, Fijneman RJ, Stoker J, Meijer GA, Coupé VM. The Potential of (TARGETED) MR Colonography as a Screening Tool for Colorectal Cancer: A Cost-Effectiveness Analysis. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A631-2. PMID 27202244 DOI: 10.1016/J.Jval.2014.08.2260  0.346
2014 Greuter MJ, Lew JB, Berkhof J, Canfell K, Dekker E, Meijer GA, Coupe VM. Long-Term Impact of the Dutch Colorectal Cancer Screening Programme on Cancer Incidence: Exploration of the Serrated Pathway. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A323. PMID 27200528 DOI: 10.1016/J.Jval.2014.08.565  0.382
2014 van Turenhout ST, Oort FA, van der Hulst RW, Visscher AP, Terhaar sive Droste JS, Scholten P, Bouman AA, Meijer GA, Mulder CJ, van Rossum LG, Coupé VM. Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer? Bmc Gastroenterology. 14: 217. PMID 25528043 DOI: 10.1186/S12876-014-0217-7  0.343
2014 Krijgsman O, Benner C, Meijer GA, van de Wiel MA, Ylstra B. FocalCall: An R Package for the Annotation of Focal Copy Number Aberrations. Cancer Informatics. 13: 153-6. PMID 25506197 DOI: 10.4137/Cin.S19519  0.307
2014 Haan JC, Labots M, Rausch C, Koopman M, Tol J, Mekenkamp LJ, van de Wiel MA, Israeli D, van Essen HF, van Grieken NC, Voorham QJ, Bosch LJ, Qu X, Kabbarah O, Verheul HM, ... ... Meijer GA, et al. Genomic landscape of metastatic colorectal cancer. Nature Communications. 5: 5457. PMID 25394515 DOI: 10.1038/Ncomms6457  0.43
2014 Maffei M, Mongera S, Terpstra L, Donadini A, Voorham QJ, Meijer GA, Giaretti W, Carvalho B, Castagnola P. Chromosome 20 aberrations at the diploid-aneuploid transition in sporadic colorectal cancer. Cytogenetic and Genome Research. 144: 9-14. PMID 25323042 DOI: 10.1159/000367909  0.374
2014 Sie D, Snijders PJ, Meijer GA, Doeleman MW, van Moorsel MI, van Essen HF, Eijk PP, Grünberg K, van Grieken NC, Thunnissen E, Verheul HM, Smit EF, Ylstra B, Heideman DA. Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology. Cellular Oncology (Dordrecht). 37: 353-61. PMID 25209392 DOI: 10.1007/S13402-014-0196-2  0.308
2014 Venderbosch S, Nagtegaal ID, Maughan TS, Smith CG, Cheadle JP, Fisher D, Kaplan R, Quirke P, Seymour MT, Richman SD, Meijer GA, Ylstra B, Heideman DA, de Haan AF, Punt CJ, et al. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5322-30. PMID 25139339 DOI: 10.1158/1078-0432.Ccr-14-0332  0.362
2014 Krijgsman O, Carvalho B, Meijer GA, Steenbergen RD, Ylstra B. Focal chromosomal copy number aberrations in cancer-Needles in a genome haystack. Biochimica Et Biophysica Acta. 1843: 2698-2704. PMID 25110350 DOI: 10.1016/J.Bbamcr.2014.08.001  0.405
2014 Goos JA, Hiemstra AC, Coupé VM, Diosdado B, Kooijman W, Delis-Van Diemen PM, Karga C, Beliën JA, Menke-van der Houven van Oordt CW, Geldof AA, Meijer GA, Hoekstra OS, Fijneman RJ. Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases. British Journal of Cancer. 111: 749-55. PMID 24983372 DOI: 10.1038/Bjc.2014.354  0.347
2014 Draht MX, Smits KM, Tournier B, Jooste V, Chapusot C, Carvalho B, Cleven AH, Derks S, Wouters KA, Belt EJ, Stockmann HB, Bril H, Weijenberg MP, van den Brandt PA, de Bruïne AP, ... ... Meijer GA, et al. Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients. Molecular Oncology. 8: 679-88. PMID 24560444 DOI: 10.1016/J.Molonc.2014.01.011  0.348
2014 Mekenkamp LJ, Haan JC, Israeli D, van Essen HF, Dijkstra JR, van Cleef P, Punt CJ, Meijer GA, Nagtegaal ID, Ylstra B. Chromosomal copy number aberrations in colorectal metastases resemble their primary counterparts and differences are typically non-recurrent. Plos One. 9: e86833. PMID 24505270 DOI: 10.1371/Journal.Pone.0086833  0.421
2014 de Groen FL, Krijgsman O, Tijssen M, Vriend LE, Ylstra B, Hooijberg E, Meijer GA, Steenbergen RD, Carvalho B. Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression. Genes, Chromosomes & Cancer. 53: 339-48. PMID 24478024 DOI: 10.1002/Gcc.22144  0.414
2014 de Wit M, Kant H, Piersma SR, Pham TV, Mongera S, van Berkel MP, Boven E, Pontén F, Meijer GA, Jimenez CR, Fijneman RJ. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling. Journal of Proteomics. 99: 26-39. PMID 24418523 DOI: 10.1016/J.Jprot.2014.01.001  0.409
2014 Labots M, Buffart TE, Haan JC, van Grieken NC, Tijssen M, van de Velde CJ, Grabsch HI, Ylstra B, Carvalho B, Fijneman RJ, Verheul HM, Meijer GA. High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection. Cellular Oncology (Dordrecht). 37: 41-52. PMID 24379144 DOI: 10.1007/S13402-013-0162-4  0.364
2014 Knol JC, de Wit M, Albrethsen J, Piersma SR, Pham TV, Mongera S, Carvalho B, Fijneman RJ, Meijer GA, Jiménez CR. Proteomics of differential extraction fractions enriched for chromatin-binding proteins from colon adenoma and carcinoma tissues. Biochimica Et Biophysica Acta. 1844: 1034-43. PMID 24361553 DOI: 10.1016/J.Bbapap.2013.12.006  0.356
2014 Snaebjornsson P, Coupe VM, Jonasson L, Meijer GA, van Grieken NC, Jonasson JG. pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited. International Journal of Cancer. Journal International Du Cancer. 135: 467-78. PMID 24347179 DOI: 10.1002/Ijc.28676  0.333
2014 Belt EJ, Stockmann HB, Delis-van Diemen PM, Bril H, Tijssen M, van Essen HF, Heymans MW, Beliën JA, Carvalho B, Cillessen SA, Meijer GA. Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence. Journal of Surgical Oncology. 109: 255-65. PMID 24249458 DOI: 10.1002/Jso.23495  0.363
2014 van Boerdonk RA, Daniels JM, Snijders PJ, Grünberg K, Thunnissen E, van de Wiel MA, Ylstra B, Postmus PE, Meijer CJ, Meijer GA, Smit EF, Sutedja TG, Heideman DA. DNA copy number aberrations in endobronchial lesions: a validated predictor for cancer. Thorax. 69: 451-7. PMID 24227199 DOI: 10.1136/Thoraxjnl-2013-203821  0.373
2014 Greuter MJ, Xu XM, Lew JB, Dekker E, Kuipers EJ, Canfell K, Meijer GA, Coupé VM. Modeling the Adenoma and Serrated pathway to Colorectal CAncer (ASCCA). Risk Analysis : An Official Publication of the Society For Risk Analysis. 34: 889-910. PMID 24172539 DOI: 10.1111/risa.12137  0.353
2014 Than BL, Goos JA, Sarver AL, O'Sullivan MG, Rod A, Starr TK, Fijneman RJ, Meijer GA, Zhao L, Zhang Y, Largaespada DA, Scott PM, Cormier RT. The role of KCNQ1 in mouse and human gastrointestinal cancers. Oncogene. 33: 3861-8. PMID 23975432 DOI: 10.1038/Onc.2013.350  0.376
2014 Broek Evd, Krijgsman O, Sie D, Haan J, Komor M, Traets J, Heideman D, Wiel Mvd, Nagtegaal I, Punt C, Carvalho B, Ylstra B, Meijer G, Fijneman R. Abstract 4285: Structural variant breakpoint detection in advanced colorectal cancer Cancer Research. 74: 4285-4285. DOI: 10.1158/1538-7445.Am2014-4285  0.45
2014 Scheinin I, Thuijl HFv, Sie D, Essen HFv, Eijk PP, Rustenburg F, Idbaih A, Alentorn A, Meijer GA, Wiel MAvd, Bengtsson H, Olshen A, Aronica E, Heimans JJ, Reijneveld JC, et al. Abstract 3426: A novel approach to copy number assessment by whole genome sequencing reveals extensive spatial heterogeneity in diffuse low-grade glioma Cancer Research. 74: 3426-3426. DOI: 10.1158/1538-7445.Am2014-3426  0.356
2014 Goos JACM, Hiemstra AC, Coupé VMH, Diosdado B, Kooijman W, Diemen PMD, Karga C, Beliën JAM, Oordt CWMdHv, Geldof AA, Meijer GA, Hoekstra OS, Fijneman RJA. Abstract 2853: Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for metastatic colorectal cancer Cancer Research. 74: 2853-2853. DOI: 10.1158/1538-7445.Am2014-2853  0.384
2014 Hooijberg E, Turksma AW, Shamier M, Lam K, Coupe VM, Weger VAd, Belien JA, Eertwegh AJvd, Meijer GA, Meijer CJ. Abstract 1649: Extent and location of tumor infiltrating lymphocytes in colon cancer predicts outcome to adjuvant active specific immunotherapy Cancer Research. 74: 1649-1649. DOI: 10.1158/1538-7445.Am2014-1649  0.339
2014 Verbeek J, Goos JA, Geldof AA, Hiemstra AC, Hoekstra OS, Meijer GA, Stroud S, Bradley D, Fijneman RJ, Windhorst AD. Abstract 112: Synthesis and preclinical evaluation of radiolabeled alisertib as an investigational aurora kinase A PET tracer Cancer Research. 74: 112-112. DOI: 10.1158/1538-7445.Am2014-112  0.32
2014 Grieken NCTv, Aoyama T, Chambers P, Bottomley D, Ward L, Inam I, Buffart T, Das K, Lim T, Pang B, Zhang S, Tan I, Carvalho B, Heideman DAM, Miyagi Y, ... ... Meijer GA, et al. KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study (vol 108, pg 1495, 2013) British Journal of Cancer. 110: 546-546. DOI: 10.1038/Bjc.2013.824  0.34
2013 Voorham QJ, Janssen J, Tijssen M, Snellenberg S, Mongera S, van Grieken NC, Grabsch H, Kliment M, Rembacken BJ, Mulder CJ, van Engeland M, Meijer GA, Steenbergen RD, Carvalho B. Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas. Bmc Cancer. 13: 603. PMID 24350795 DOI: 10.1186/1471-2407-13-603  0.349
2013 Goos JA, Coupe VM, Diosdado B, Delis-Van Diemen PM, Karga C, Beliën JA, Carvalho B, van den Tol MP, Verheul HM, Geldof AA, Meijer GA, Hoekstra OS, Fijneman RJ. Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis. British Journal of Cancer. 109: 2445-52. PMID 24104968 DOI: 10.1038/Bjc.2013.608  0.375
2013 Snoeren N, Emmink BL, Koerkamp MJ, van Hooff SR, Goos JA, van Houdt WJ, de Wit M, Prins AM, Piersma SR, Pham TV, Belt EJ, Bril H, Stockmann HB, Meijer GA, van Hillegersberg R, et al. Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer. British Journal of Cancer. 109: 1636-47. PMID 24002600 DOI: 10.1038/Bjc.2013.489  0.371
2013 Hubers AJ, Heideman DA, Yatabe Y, Wood MD, Tull J, Tarón M, Molina MA, Mayo C, Bertran-Alamillo J, Herder GJ, Koning R, Sie D, Ylstra B, Meijer GA, Snijders PJ, et al. EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study. Lung Cancer (Amsterdam, Netherlands). 82: 38-43. PMID 23927883 DOI: 10.1016/J.Lungcan.2013.07.011  0.307
2013 Neerincx M, Buffart TE, Mulder CJ, Meijer GA, Verheul HM. The future of colorectal cancer: implications of screening. Gut. 62: 1387-9. PMID 23749605 DOI: 10.1136/Gutjnl-2013-305023  0.382
2013 Simons CC, Hughes LA, Smits KM, Khalid-de Bakker CA, de Bruïne AP, Carvalho B, Meijer GA, Schouten LJ, van den Brandt PA, Weijenberg MP, van Engeland M. A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 2048-56. PMID 23532114 DOI: 10.1093/Annonc/Mdt076  0.384
2013 van Grieken NC, Aoyama T, Aoyma T, Chambers PA, Bottomley D, Ward LC, Inam I, Buffart TE, Das K, Lim T, Pang B, Zhang SL, Tan IB, Carvalho B, Heideman DA, ... ... Meijer GA, et al. KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: results from a large international multicentre study. British Journal of Cancer. 108: 1495-501. PMID 23511561 DOI: 10.1038/Bjc.2013.109  0.34
2013 de Cuba EM, Kwakman R, Knol DL, Bonjer HJ, Meijer GA, Te Velde EA. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies. Cancer Treatment Reviews. 39: 321-7. PMID 23244778 DOI: 10.1016/J.Ctrv.2012.11.003  0.337
2013 Dijkstra JR, Heideman DA, Meijer GA, Boers JE, 't Hart NA, Diebold J, Hirschmann A, Hoefler G, Winter G, Miltenberger-Miltenyi G, Pereira SV, Richman SD, Quirke P, Rouleau EL, Guinebretiere JM, et al. KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assurance. Virchows Archiv : An International Journal of Pathology. 462: 39-46. PMID 23242173 DOI: 10.1007/S00428-012-1356-2  0.315
2013 de Wit M, Fijneman RJ, Verheul HM, Meijer GA, Jimenez CR. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications. Clinical Biochemistry. 46: 466-79. PMID 23159294 DOI: 10.1016/J.Clinbiochem.2012.10.039  0.379
2013 Krijgsman O, Israeli D, van Essen HF, Eijk PP, Berens ML, Mellink CH, Nieuwint AW, Weiss MM, Steenbergen RD, Meijer GA, Ylstra B. Detection limits of DNA copy number alterations in heterogeneous cell populations. Cellular Oncology (Dordrecht). 36: 27-36. PMID 23117839 DOI: 10.1007/S13402-012-0108-2  0.319
2013 Bierkens M, Krijgsman O, Wilting SM, Bosch L, Jaspers A, Meijer GA, Meijer CJ, Snijders PJ, Ylstra B, Steenbergen RD. Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis. Genes, Chromosomes & Cancer. 52: 56-68. PMID 22987659 DOI: 10.1002/Gcc.22006  0.309
2013 de Wit M, Belt EJ, Delis-van Diemen PM, Carvalho B, Coupé VM, Stockmann HB, Bril H, Beliën JA, Fijneman RJ, Meijer GA. Lumican and versican are associated with good outcome in stage II and III colon cancer. Annals of Surgical Oncology. 20: S348-59. PMID 22711178 DOI: 10.1245/S10434-012-2441-0  0.401
2013 Mekenkamp LJ, Haan JC, Koopman M, Vink-Börger ME, Israeli D, Teerenstra S, Ylstra B, Meijer GA, Punt CJ, Nagtegaal ID. Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancer. Gut. 62: 94-101. PMID 22267596 DOI: 10.1136/Gutjnl-2011-301587  0.381
2013 Carvalho B, Bosch LJW, Engeland Mv, Meijer GA. Molecular markers and the future of colorectal cancer screening Colorectal Cancer. 2: 95-97. DOI: 10.2217/Crc.12.81  0.405
2013 Kim JJ, Labots M, Marchionni L, Begum S, Meijer GA, Verheul HMW, Carducci MA, Hammers HJ, Allaf M, Netto GJ, Hoque M. Genome-wide methylation profiling to identify potential epigenetic biomarkers associated with response to sunitinib in metastatic renal cell cancer (mRCC) patients (pts). Journal of Clinical Oncology. 31: 4566-4566. DOI: 10.1200/Jco.2013.31.15_Suppl.4566  0.308
2013 Criekinge WV, Bosch LJ, Trooskens G, Snaebjornsson P, Haan J, Pelosof LC, Koopman M, Tol J, Louwagie J, Dehaspe L, Grieken NCTv, Ylstra B, Verheul HMW, Engeland Mv, Nagtegaal ID, ... ... Meijer GA, et al. Association of DNA promoter hypermethylation of decoy receptor 1 (DCR1) with poor response to irinotecan in metastatic colorectal cancer. Journal of Clinical Oncology. 31: 3552-3552. DOI: 10.1200/Jco.2013.31.15_Suppl.3552  0.369
2013 Krijgsman O, Haan J, Carvalho B, Meijer GA, Ylstra B. Abstract 3154: Genomic landscape of metastatic colorectal cancer. Cancer Research. 73: 3154-3154. DOI: 10.1158/1538-7445.Am2013-3154  0.481
2013 Diosdado B, Droste JSTs, Bolijn AS, Burink MKv, Grieken NCv, Carvalho B, Mulder CJ, Meijer GA. Abstract 1197: Chromosomal aberrations implicated in colorectal adenoma to carcinoma progression as markers of high risk colorectal adenomas. Cancer Research. 73: 1197-1197. DOI: 10.1158/1538-7445.Am2013-1197  0.45
2013 Bosch LJ, Trooskens G, Snaebjornsson P, Haan JC, Pelosof L, Koopman M, Tol J, Louwagie J, Dehaspe L, Ylstra B, Verheul H, Engeland Mv, Nagtegaal ID, Herman JG, Punt CJ, ... ... Meijer GA, et al. Abstract 1155: Promoter CpG island hypermethylation of Decoy Receptor 1 (DCR1) is associated with poor response to irinotecan in colorectal cancer. Cancer Research. 73: 1155-1155. DOI: 10.1158/1538-7445.Am2013-1155  0.39
2013 Goos JACM, Coupé VMH, Diosdado B, Diemen PMD, Karga C, Beliën JAM, Carvalho B, Tol MPvd, Verheul HMW, Geldof AA, Meijer GA, Hoekstra OS, Fijneman RJA. Abstract 1151: Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis. Cancer Research. 73: 1151-1151. DOI: 10.1158/1538-7445.Am2013-1151  0.41
2013 Clercq Cl, Riedl R, Bouwens M, Carvalho B, Meijer GA, Engeland Mv, Winkens B, Masclee A, Sanduleanu S. Sa1689 Microsatellite Instability, BRAF and KRAS Mutation in Postcolonoscopy Cancers: An Explorative Study Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)61002-1  0.346
2013 Larbi IB, Buth AJ, Coupe VM, Hulst RWvd, Scholten P, Tuynman H, Meijer GA, Mulder CJ, Droste JSTs. Sa1180 Low Incidence of Post-Colonoscopy Colorectal Cancer During Six Years of Follow-up: A Population-Based Cohort Study Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)60786-6  0.36
2013 Greuter MJ, Xu X, Lew J, Dekker E, Kuipers EJ, Canfell K, Meijer GA, Coupe VM. Sa1163 Modelling the Adenoma and Serrated Pathway to Colorectal Cancer (ASCCA) Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)60769-6  0.381
2012 Belt EJ, Stockmann HB, Abis GS, de Boer JM, de Lange-de Klerk ES, van Egmond M, Meijer GA, Oosterling SJ. Peri-operative bowel perforation in early stage colon cancer is associated with an adverse oncological outcome. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 16: 2260-6. PMID 23093449 DOI: 10.1007/S11605-012-2053-9  0.391
2012 Vincenten J, Smit EF, Vos W, Grünberg K, Postmus PE, Heideman DA, Snijders PJ, Meijer G, Kuik J, Witte BI, Thunnissen E. Negative NKX2-1 (TTF-1) as temporary surrogate marker for treatment selection during EGFR-mutation analysis in patients with non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 1522-7. PMID 22982653 DOI: 10.1097/Jto.0B013E3182635A91  0.319
2012 Sanduleanu S, Masclee AM, Meijer GA. Interval cancers after colonoscopy-insights and recommendations. Nature Reviews. Gastroenterology & Hepatology. 9: 550-4. PMID 22907162 DOI: 10.1038/Nrgastro.2012.136  0.391
2012 Morris AR, Bos A, Diosdado B, Rooijers K, Elkon R, Bolijn AS, Carvalho B, Meijer GA, Agami R. Alternative cleavage and polyadenylation during colorectal cancer development. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5256-66. PMID 22874640 DOI: 10.1158/1078-0432.Ccr-12-0543  0.4
2012 de Wijkerslooth TR, Stoop EM, Bossuyt PM, Meijer GA, van Ballegooijen M, van Roon AH, Stegeman I, Kraaijenhagen RA, Fockens P, van Leerdam ME, Dekker E, Kuipers EJ. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. The American Journal of Gastroenterology. 107: 1570-8. PMID 22850431 DOI: 10.1038/Ajg.2012.249  0.321
2012 Voorham QJ, Carvalho B, Spiertz AJ, Claes B, Mongera S, van Grieken NC, Grabsch H, Kliment M, Rembacken B, van de Wiel MA, Quirke P, Mulder CJ, Lambrechts D, van Engeland M, Meijer GA. Comprehensive mutation analysis in colorectal flat adenomas. Plos One. 7: e41963. PMID 22848674 DOI: 10.1371/Journal.Pone.0041963  0.366
2012 Terhaar sive Droste JS, van Turenhout ST, Oort FA, van der Hulst RW, Steeman VA, Coblijn U, van der Eem L, Duijkers R, Bouman AA, Meijer GA, Depla AC, Scholten P, Loffeld RJ, Coupé VM, Mulder CJ. Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study. Bmc Gastroenterology. 12: 94. PMID 22828158 DOI: 10.1186/1471-230X-12-94  0.378
2012 de Cuba EM, Kwakman R, van Egmond M, Bosch LJ, Bonjer HJ, Meijer GA, te Velde EA. Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers. Virchows Archiv : An International Journal of Pathology. 461: 231-43. PMID 22825001 DOI: 10.1007/S00428-012-1287-Y  0.397
2012 Bosch LJ, Mongera S, Terhaar Sive Droste JS, Oort FA, van Turenhout ST, Penning MT, Louwagie J, Mulder CJ, van Engeland M, Carvalho B, Meijer GA. Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection. Cellular Oncology (Dordrecht). 35: 309-15. PMID 22821210 DOI: 10.1007/S13402-012-0092-6  0.342
2012 Mekenkamp LJ, Tol J, Dijkstra JR, de Krijger I, Vink-Börger ME, van Vliet S, Teerenstra S, Kamping E, Verwiel E, Koopman M, Meijer GA, van Krieken JH, Kuiper R, Punt CJ, Nagtegaal ID. Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients. Bmc Cancer. 12: 292. PMID 22804917 DOI: 10.1186/1471-2407-12-292  0.355
2012 Voorham QJ, Carvalho B, Spiertz AJ, van Grieken NC, Mongera S, Rondagh EJ, van de Wiel MA, Jordanova ES, Ylstra B, Kliment M, Grabsch H, Rembacken BJ, Arai T, de Bruïne AP, Sanduleanu S, ... ... Meijer GA, et al. Chromosome 5q loss in colorectal flat adenomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4560-9. PMID 22761468 DOI: 10.1158/1078-0432.Ccr-11-2385  0.387
2012 van Turenhout ST, Oort FA, Terhaar sive Droste JS, Coupé VM, van der Hulst RW, Loffeld RJ, Scholten P, Depla AC, Bouman AA, Meijer GA, Mulder CJ, van Rossum LG. Hemorrhoids detected at colonoscopy: an infrequent cause of false-positive fecal immunochemical test results. Gastrointestinal Endoscopy. 76: 136-43. PMID 22726472 DOI: 10.1016/J.Gie.2012.03.169  0.341
2012 Sillars-Hardebol AH, Carvalho B, Beliën JA, de Wit M, Delis-van Diemen PM, Tijssen M, van de Wiel MA, Pontén F, Meijer GA, Fijneman RJ. CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression. Cellular Oncology (Dordrecht). 35: 293-300. PMID 22711543 DOI: 10.1007/S13402-012-0088-2  0.398
2012 Zaal A, Peyrot WJ, Berns PM, van der Burg ME, Veerbeek JH, Trimbos JB, Cadron I, van Diest PJ, van Wieringen WN, Krijgsman O, Meijer GA, Piek JM, Timmers PJ, Vergote I, Verheijen RH, et al. Genomic aberrations relate early and advanced stage ovarian cancer. Cellular Oncology (Dordrecht). 35: 181-8. PMID 22581446 DOI: 10.1007/S13402-012-0077-5  0.359
2012 Buffart TE, Carvalho B, van Grieken NC, van Wieringen WN, Tijssen M, Kranenbarg EM, Verheul HM, Grabsch HI, Ylstra B, van de Velde CJ, Meijer GA. Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer. The Oncologist. 17: 653-62. PMID 22531355 DOI: 10.1634/Theoncologist.2010-0379  0.405
2012 Carvalho J, van Grieken NC, Pereira PM, Sousa S, Tijssen M, Buffart TE, Diosdado B, Grabsch H, Santos MA, Meijer G, Seruca R, Carvalho B, Oliveira C. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. The Journal of Pathology. 228: 31-44. PMID 22450781 DOI: 10.1002/Path.4032  0.308
2012 Draht MX, Riedl RR, Niessen H, Carvalho B, Meijer GA, Herman JG, van Engeland M, Melotte V, Smits KM. Promoter CpG island methylation markers in colorectal cancer: the road ahead. Epigenomics. 4: 179-94. PMID 22449189 DOI: 10.2217/Epi.12.9  0.376
2012 Fijneman RJ, de Wit M, Pourghiasian M, Piersma SR, Pham TV, Warmoes MO, Lavaei M, Piso C, Smit F, Delis-van Diemen PM, van Turenhout ST, Terhaar sive Droste JS, Mulder CJ, Blankenstein MA, Robanus-Maandag EC, ... ... Meijer GA, et al. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 2613-24. PMID 22351690 DOI: 10.1158/1078-0432.Ccr-11-1937  0.389
2012 Belt EJ, Brosens RP, Delis-van Diemen PM, Bril H, Tijssen M, van Essen DF, Heymans MW, Beliën JA, Stockmann HB, Meijer S, Meijer GA. Cell cycle proteins predict recurrence in stage II and III colon cancer. Annals of Surgical Oncology. 19: S682-92. PMID 22311118 DOI: 10.1245/S10434-012-2216-7  0.345
2012 van Turenhout ST, Terhaar sive Droste JS, Meijer GA, Masclée AA, Mulder CJ. Anticipating implementation of colorectal cancer screening in The Netherlands: a nation wide survey on endoscopic supply and demand. Bmc Cancer. 12: 46. PMID 22280408 DOI: 10.1186/1471-2407-12-46  0.366
2012 Carvalho B, Sillars-Hardebol AH, Postma C, Mongera S, Terhaar Sive Droste J, Obulkasim A, van de Wiel M, van Criekinge W, Ylstra B, Fijneman RJ, Meijer GA. Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism. Cellular Oncology (Dordrecht). 35: 53-63. PMID 22278361 DOI: 10.1007/S13402-011-0065-1  0.364
2012 Sillars-Hardebol AH, Carvalho B, Tijssen M, Beliën JA, de Wit M, Delis-van Diemen PM, Pontén F, van de Wiel MA, Fijneman RJ, Meijer GA. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression. Gut. 61: 1568-75. PMID 22207630 DOI: 10.1136/Gutjnl-2011-301153  0.42
2012 Fijneman RJ, Anderson RA, Richards E, Liu J, Tijssen M, Meijer GA, Anderson J, Rod A, O'Sullivan MG, Scott PM, Cormier RT. Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract. Cancer Science. 103: 593-9. PMID 22171576 DOI: 10.1111/J.1349-7006.2011.02189.X  0.303
2012 Krijgsman O, Israeli D, Haan JC, van Essen HF, Smeets SJ, Eijk PP, Steenbergen RD, Kok K, Tejpar S, Meijer GA, Ylstra B. CGH arrays compared for DNA isolated from formalin-fixed, paraffin-embedded material. Genes, Chromosomes & Cancer. 51: 344-52. PMID 22162309 DOI: 10.1002/Gcc.21920  0.31
2012 de Weger VA, Turksma AW, Voorham QJ, Euler Z, Bril H, van den Eertwegh AJ, Bloemena E, Pinedo HM, Vermorken JB, van Tinteren H, Meijer GA, Hooijberg E. Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 882-9. PMID 22156611 DOI: 10.1158/1078-0432.Ccr-11-1716  0.368
2012 Bosch LJ, Oort FA, Neerincx M, Khalid-de Bakker CA, Terhaar sive Droste JS, Melotte V, Jonkers DM, Masclee AA, Mongera S, Grooteclaes M, Louwagie J, van Criekinge W, Coupé VM, Mulder CJ, van Engeland M, ... ... Meijer GA, et al. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT. Cancer Prevention Research (Philadelphia, Pa.). 5: 464-72. PMID 22135045 DOI: 10.1158/1940-6207.Capr-11-0315  0.388
2012 Capelle LG, den Hoed CM, de Vries AC, Biermann K, Casparie MK, Meijer GA, Kuipers EJ. Premalignant gastric lesions in patients with gastric mucosa-associated lymphoid tissue lymphoma and metachronous gastric adenocarcinoma: a case-control study. European Journal of Gastroenterology & Hepatology. 24: 42-7. PMID 22081006 DOI: 10.1097/Meg.0B013E32834D85E6  0.313
2012 Sillars-Hardebol AH, Carvalho B, Beliën JA, de Wit M, Delis-van Diemen PM, Tijssen M, van de Wiel MA, Pontén F, Fijneman RJ, Meijer GA. BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain. The Journal of Pathology. 226: 442-50. PMID 22009326 DOI: 10.1002/Path.2983  0.419
2012 Belt EJ, te Velde EA, Krijgsman O, Brosens RP, Tijssen M, van Essen HF, Stockmann HB, Bril H, Carvalho B, Ylstra B, Bonjer HJ, Meijer GA. High lymph node yield is related to microsatellite instability in colon cancer. Annals of Surgical Oncology. 19: 1222-30. PMID 21989661 DOI: 10.1245/S10434-011-2091-7  0.372
2012 Sillars-Hardebol AH, Carvalho B, van Engeland M, Fijneman RJ, Meijer GA. The adenoma hunt in colorectal cancer screening: defining the target. The Journal of Pathology. 226: 1-6. PMID 21984228 DOI: 10.1002/Path.3012  0.419
2012 de Wit M, Jimenez CR, Carvalho B, Belien JA, Delis-van Diemen PM, Mongera S, Piersma SR, Vikas M, Navani S, Pontén F, Meijer GA, Fijneman RJ. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression. Gut. 61: 855-64. PMID 21890811 DOI: 10.1136/Gutjnl-2011-300511  0.356
2012 Saeland E, Belo AI, Mongera S, van Die I, Meijer GA, van Kooyk Y. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients. International Journal of Cancer. Journal International Du Cancer. 131: 117-28. PMID 21823122 DOI: 10.1002/Ijc.26354  0.351
2012 Haan JC, Buffart TE, Eijk PP, van de Wiel MA, van Wieringen WN, Howdle PD, Mulder CJ, van de Velde CJ, Quirke P, Nagtegaal ID, van Grieken NC, Grabsch H, Meijer GA, Ylstra B. Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 23: 367-74. PMID 21586687 DOI: 10.1093/Annonc/Mdr122  0.44
2012 Wit Md, Belt EJ, Diemen PMDv, Carvalho B, Coupé VM, Stockmann HB, Bril H, Belien JA, Fijneman RJ, Meijer GA. Abstract 4526: Lumican and Versican predict good outcome in stage II and III colon cancer Cancer Research. 72: 4526-4526. DOI: 10.1158/1538-7445.Am2012-4526  0.386
2012 Bosch LJ, Wit Md, Oudgenoeg G, Hiemstra A, Mongera S, Piersma SR, Pham TV, Grieken NCv, Droste JSTs, Oort FA, Turenhout STv, Larbi IB, Mulder CJ, Carvalho B, Jimenez CR, ... ... Meijer GA, et al. Abstract 4523: Stool proteomics reveals new candidate biomarkers for colorectal cancer screening Cancer Research. 72: 4523-4523. DOI: 10.1158/1538-7445.Am2012-4523  0.34
2012 Sillars-Hardebol AH, Carvalho B, Belien JAM, Wit Md, Diemen PMD, Tijssen M, Wiel MAvd, Ponten F, Meijer GA, Fijneman RJA. Abstract 109: CSE1L, a 20q gain passenger that drives colorectal adenoma to carcinoma progression Cancer Research. 72: 109-109. DOI: 10.1158/1538-7445.Am2012-109  0.415
2012 Larbi IB, Turenhout STV, Oort FA, Droste JSTs, Hulst RWvd, Scholten P, Loffeld RJ, Depla A, Coupe VM, Bouman AA, Meijer GA, Mulder CJ. Tu1200 Fecal Immunochemical Test Results in Different Stages of Colorectal Cancer: A Colonoscopy Controlled Study Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)62993-X  0.379
2012 Droste JSTs, Bolijn AS, Burink M, van, Grieken NCv, Carvalho B, Mulder CJ, Meijer GA, Diosdado B. Mo1620 Chromosomal Aberrations Implicated in Colorectal Adenoma to Carcinoma Progression as Markers of High Risk Colorectal Adenomas Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)62475-5  0.379
2012 Fijneman RJ, Wit Md, Piersma SR, Pham TV, Turenhout STV, Droste JSTs, Mulder CJ, Blankenstein MA, Robanus-Maandag EC, Smits R, Fodde R, Hinsbergh VWv, Meijer GA, Jimenez CR. Su1876 Proximal Fluid Proteome Profiling of Mouse Colon Tumors Reveals Biomarkers for Early Diagnosis of Human Colorectal Cancer Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)62015-0  0.383
2012 Bosch LJ, Wit Md, Oudgenoeg G, Hiemstra AC, Mongera S, Piersma SR, Pham TV, Grieken NCv, Droste JSTs, Oort FA, Turenhout STV, Larbi IB, Mulder CJ, Carvalho B, Jimenez CR, ... ... Meijer GA, et al. Su1874 Stool Proteomics Reveals New Candidate Biomarkers for Colorectal Cancer Screening Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)62013-7  0.384
2011 van Boerdonk RA, Sutedja TG, Snijders PJ, Reinen E, Wilting SM, van de Wiel MA, Thunnissen FE, Duin S, Kooi C, Ylstra B, Meijer CJ, Meijer GA, Grünberg K, Daniels JM, Postmus PE, et al. DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancer. American Journal of Respiratory and Critical Care Medicine. 184: 948-56. PMID 21799074 DOI: 10.1164/Rccm.201102-0218Oc  0.363
2011 Khalid-de Bakker CA, Jonkers DM, Sanduleanu S, de Bruïne AP, Meijer GA, Janssen JB, van Engeland M, Stockbrügger RW, Masclee AA. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas. Cancer Prevention Research (Philadelphia, Pa.). 4: 1563-71. PMID 21750209 DOI: 10.1158/1940-6207.Capr-11-0076  0.324
2011 Brosens RP, Belt EJ, Haan JC, Buffart TE, Carvalho B, Grabsch H, Quirke P, Cuesta MA, Engel AF, Ylstra B, Meijer GA. Deletion of chromosome 4q predicts outcome in stage II colon cancer patients. Cellular Oncology (Dordrecht). 34: 215-23. PMID 21717218 DOI: 10.1007/S13402-011-0042-8  0.411
2011 Smeets SJ, Harjes U, van Wieringen WN, Sie D, Brakenhoff RH, Meijer GA, Ylstra B. To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic! Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4959-64. PMID 21673065 DOI: 10.1158/1078-0432.Ccr-11-0462  0.34
2011 Belt EJ, Fijneman RJ, van den Berg EG, Bril H, Delis-van Diemen PM, Tijssen M, van Essen HF, de Lange-de Klerk ES, Beliën JA, Stockmann HB, Meijer S, Meijer GA. Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence. European Journal of Cancer (Oxford, England : 1990). 47: 1837-45. PMID 21621406 DOI: 10.1016/J.Ejca.2011.04.025  0.383
2011 Bosch LJ, Carvalho B, Fijneman RJ, Jimenez CR, Pinedo HM, van Engeland M, Meijer GA. Molecular tests for colorectal cancer screening. Clinical Colorectal Cancer. 10: 8-23. PMID 21609931 DOI: 10.3816/Ccc.2011.N.002  0.378
2011 Buffart TE, Louw M, van Grieken NC, Tijssen M, Carvalho B, Ylstra B, Grabsch H, Mulder CJ, van de Velde CJ, van der Merwe SW, Meijer GA. Gastric cancers of Western European and African patients show different patterns of genomic instability. Bmc Medical Genomics. 4: 7. PMID 21226972 DOI: 10.1186/1755-8794-4-7  0.404
2011 Curvers WL, van Vilsteren FG, Baak LC, Böhmer C, Mallant-Hent RC, Naber AH, van Oijen A, Ponsioen CY, Scholten P, Schenk E, Schoon E, Seldenrijk CA, Meijer GA, ten Kate FJ, Bergman JJ. Endoscopic trimodal imaging versus standard video endoscopy for detection of early Barrett's neoplasia: a multicenter, randomized, crossover study in general practice. Gastrointestinal Endoscopy. 73: 195-203. PMID 21168835 DOI: 10.1016/J.Gie.2010.10.014  0.304
2011 Terhaar sive Droste JS, Oort FA, van der Hulst RW, van Heukelem HA, Loffeld RJ, van Turenhout ST, Ben Larbi I, Kanis SL, Neerincx M, Räkers M, Coupé VM, Bouman AA, Meijer GA, Mulder CJ. Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 272-80. PMID 21135261 DOI: 10.1158/1055-9965.Epi-10-0848  0.372
2011 Vink JM, Kemenade FJv, Meijer CJLM, Casparie MK, Meijer GA, Boomsma DI. Cervix smear abnormalities: linking pathology data in female twins, their mothers and sisters. European Journal of Human Genetics. 19: 108-111. PMID 20717168 DOI: 10.1038/Ejhg.2010.139  0.334
2011 Goos JACM, Fijneman RJA, Geldof AA, Meijer GA, Hoekstra OS. Abstract 5217: MMP9 is a prognostic biomarker for metastatic colorectal cancer Cancer Research. 71: 5217-5217. DOI: 10.1158/1538-7445.Am2011-5217  0.41
2011 Lavaei M, Fijneman RJ, Fluitsma D, Knol JC, Piersma SR, Pham TV, Steenbergen R, Meijer GA, Verheul HM, Pegtel M, Jimenez CR. Abstract 5115: Comparative proteomics of exosomes secreted by a panel of cancer cell lines Cancer Research. 71: 5115-5115. DOI: 10.1158/1538-7445.Am2011-5115  0.34
2011 Labots M, Haan JC, Buffart TE, Grieken NCv, Tijssen M, Ylstra B, Carvalho B, Velde CJvd, Grabsch HI, Verheul HM, Fijneman RJ, Meijer GA. Abstract 3941: Amplifications of drug target genes in gastric cancer: Potential clinical implications Cancer Research. 71: 3941-3941. DOI: 10.1158/1538-7445.Am2011-3941  0.378
2011 Sillars-Hardebol AH, Carvalho B, Tijssen M, Beliën JAM, Wit Md, Diemen PMD, Pontén F, Wiel MAvd, Fijneman RJA, Meijer GA. Abstract 3042: TPX2 and AURKA promote 20q amplicon driven colorectal adenoma-to-carcinoma progression Cancer Research. 71: 3042-3042. DOI: 10.1158/1538-7445.Am2011-3042  0.426
2011 Mekenkamp LJM, Tol J, Dijkstra J, Krijger ID, Vink-Borger ME, Teerenstra S, Verwiel E, Koopman M, Meijer GA, Krieken JHJMv, Kuiper R, Punt CJA, Nagtegaal ID. Abstract 235: BeyondKRASmutation status: Influence ofKRAScopy number alteration and microRNAs in response to cetuximab in metastatic colorectal cancer patients Cancer Research. 71: 235-235. DOI: 10.1158/1538-7445.Am2011-235  0.385
2011 Droste JSTs, Oort FA, Turenhout STv, Meijer GA, Mulder CJJ. FIT Performance in Early-Stage Colorectal Cancer—Response Cancer Epidemiology, Biomarkers & Prevention. 20: 1563-1563. DOI: 10.1158/1055-9965.Epi-11-0353  0.382
2011 Hoed CMd, Capelle L, Tijssen M, Ylstra B, Meijer GA, Kuipers EJ, Grieken NCv, Vasen HF. Chromosomal Changes in Lynch Syndrome-Related Gastric Cancer Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)63394-5  0.351
2011 Turenhout STV, Droste JSTs, Meijer GA, Mulder CJ. Anticipating on Implementation of Colorectal Cancer Screening in the Netherlands: Endoscopic Demand Versus Capacity Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)61686-7  0.381
2011 Capelle L, Hoed CMd, Grieken NCv, Meijer GA, Kuipers EJ, Vasen HF. Gastric Cancer in Lynch Syndrome Patients: Is Surveillance Justified? Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)61035-4  0.351
2011 Brosens RPM, Belt EJTH, Haan JC, Buffart TE, Carvalho B, Grabsch H, Quirke P, Cuesta MA, Engel AF, Ylstra B, Meijer GA. Erratum : Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients (Analytical Cellular Pathology (2010) 33: 2 (95-104)) Cellular Oncology. 34: 279-280. DOI: 10.1007/S13402-011-0055-3  0.369
2010 Meijer GA. What makes CRCs metastasise Gut. 59: 1164-1165. PMID 20660076 DOI: 10.1136/Gut.2010.212241  0.359
2010 Jonge PJFd, Blankenstein Mv, Looman CWN, Casparie MK, Meijer GA, Kuipers EJ. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study Gut. 59: 1030-1036. PMID 20639249 DOI: 10.1136/Gut.2009.176701  0.301
2010 de Vries AC, Haringsma J, de Vries RA, Ter Borg F, van Grieken NC, Meijer GA, van Dekken H, Kuipers EJ. Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions. Helicobacter. 15: 259-64. PMID 20633186 DOI: 10.1111/J.1523-5378.2010.00760.X  0.328
2010 Belt EJT, Stijn MFMv, Bril H, Klerk ESMdL, Meijer GA, Meijer S, Stockmann HBAC. Lymph node negative colorectal cancers with isolated tumor deposits should be classified and treated as stage III. Annals of Surgical Oncology. 17: 3203-3211. PMID 20625841 DOI: 10.1245/S10434-010-1152-7  0.347
2010 Jimenez CR, Knol JC, Meijer GA, Fijneman RJA. Proteomics of colorectal cancer: Overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers Journal of Proteomics. 73: 1873-1895. PMID 20601272 DOI: 10.1016/J.Jprot.2010.06.004  0.363
2010 Brosens RPM, Haan JC, Carvalho B, Rustenburg F, Grabsch H, Quirke P, Engel AF, Cuesta MA, Maughan N, Flens M, Meijer GA, Ylstra B. Candidate driver genes in focal chromosomal aberrations of stage II colon cancer. The Journal of Pathology. 221: 411-424. PMID 20593488 DOI: 10.1002/Path.2724  0.459
2010 Droste JSTs, Oort FA, Hulst RWMvd, Coupé VMH, Craanen ME, Meijer GA, Morsink LM, Visser O, Wanrooij RLJv, Mulder CJJ. Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational study Bmc Cancer. 10: 332-332. PMID 20584274 DOI: 10.1186/1471-2407-10-332  0.358
2010 Wilting SM, Boerdonk RAAv, Henken FE, Meijer CJLM, Diosdado B, Meijer GA, Sage Cl, Agami R, Snijders PJF, Steenbergen RDM. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer Molecular Cancer. 9: 167-167. PMID 20579385 DOI: 10.1186/1476-4598-9-167  0.304
2010 Curvers WL, ten Kate FJ, Krishnadath KK, Visser M, Elzer B, Baak LC, Bohmer C, Mallant-Hent RC, van Oijen A, Naber AH, Scholten P, Busch OR, Blaauwgeers HG, Meijer GA, Bergman JJ. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated. The American Journal of Gastroenterology. 105: 1523-30. PMID 20461069 DOI: 10.1038/Ajg.2010.171  0.301
2010 Sillars-Hardebol AH, Carvalho B, de Wit M, Postma C, Delis-van Diemen PM, Mongera S, Ylstra B, van de Wiel MA, Meijer GA, Fijneman RJ. Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 31: 89-96. PMID 20358421 DOI: 10.1007/s13277-009-0012-1  0.32
2010 Diosdado B, Buffart TE, Watkins R, Carvalho B, Ylstra B, Tijssen M, Bolijn AS, Lewis F, Maude K, Verbeke C, Nagtegaal ID, Grabsch H, Mulder CJ, Quirke P, Howdle P, ... Meijer GA, et al. High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1391-401. PMID 20179237 DOI: 10.1158/1078-0432.Ccr-09-1773  0.321
2010 Albrethsen J, Knol JC, Piersma SR, Pham TV, de Wit M, Mongera S, Carvalho B, Verheul HM, Fijneman RJ, Meijer GA, Jimenez CR. Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression. Molecular & Cellular Proteomics : McP. 9: 988-1005. PMID 20089989 DOI: 10.1074/Mcp.M900546-Mcp200  0.357
2010 Oort FA, Terhaar Sive Droste JS, Van Der Hulst RW, Van Heukelem HA, Loffeld RJ, Wesdorp IC, Van Wanrooij RL, De Baaij L, Mutsaers ER, van der Reijt S, Coupe VM, Berkhof J, Bouman AA, Meijer GA, Mulder CJ. Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test. Alimentary Pharmacology & Therapeutics. 31: 432-9. PMID 19878150 DOI: 10.1111/J.1365-2036.2009.04184.X  0.314
2010 Jonge PJFd, Blankenstein Mv, Looman CWN, Casparie MK, Meijer GA, Kuipers EJ. Risk of Colorectal Cancer in Patients With Barrett's Esophagus: A Dutch Population-Based Study The American Journal of Gastroenterology. 105: 77-83. PMID 19724268 DOI: 10.1038/Ajg.2009.503  0.37
2010 Lam TJ, Meurs-Szojda MM, Gundlach L, Belien JAM, Meijer GA, Mulder CJJ, Felt-Bersma RJF. There is no increased risk for colorectal cancer and adenomas in patients with diverticulitis: a retrospective longitudinal study. Colorectal Disease. 12: 1122-1126. PMID 19575738 DOI: 10.1111/J.1463-1318.2009.01992.X  0.366
2010 Fijneman RJA, Kant H, Wit Md, Piersma SR, Pham TV, Warmoes M, Mongera S, Verheul HMW, Meijer GA, Jimenez CR. Abstract 4627: Proximal fluid proteome profiling of human colorectal cancer tissue reveals candidate biomarkers for CRC screening Cancer Research. 70: 4627-4627. DOI: 10.1158/1538-7445.Am10-4627  0.42
2010 Weger VAd, Euler Z, Tinteren Hv, Bril H, Meijer GA, Hooijberg E. Abstract 3741: Adjuvant active specific immunotherapy improves survival of patients with micro-satellite stable colorectal tumors, but not with micro-satellite instable tumors Cancer Research. 70: 3741-3741. DOI: 10.1158/1538-7445.Am10-3741  0.354
2010 Carvalho B, Postma C, Mongera S, Diemen Pv, Ylstra B, Meijer GA. Abstract 3086: Gain of chromosome 13 is a cause of CDK8 overexpression associated with colorectal adenoma to carcinoma progression Cancer Research. 70: 3086-3086. DOI: 10.1158/1538-7445.Am10-3086  0.425
2010 Leon LG, Peters GJ, Giovannetti E, Smid K, Ylstra B, Meijer GA, Giaccone G, Hanauske AR. Abstract 2146: DNA copy number profiles associated with clinical outcome in advanced colorectal cancer patients treated with folfiri and aliri regimens Cancer Research. 70: 2146-2146. DOI: 10.1158/1538-7445.Am10-2146  0.407
2010 Droste JSTs, Oort FA, Hulst RWvd, Coupe VM, Craanen M, Meijer GA, Morsink LM, Visser O, Wanrooy Rv, Mulder CJ. S1978 Delay in Diagnosing Colorectal Cancer in Symptomatic Patients Does Not Affect Tumor Stage and Survival Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)61349-2  0.389
2010 Turenhout STv, Rossum LGv, Oort FA, Laheij RJ, Rijn AFv, Fockens P, Meijer GA, Jansen JB, Dekker E, Mulder CJ. S1125 Differences in Fit Results Between Screening and Referred Colorectal Cancer Patients are Explained by Differences in Tissue Tumor Stage Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)60841-4  0.339
2010 Turenhout STv, Stegeman I, Oort FA, Ferket BS, Kalken CKv, Meijer GA, Kraaijenhagen RA, Mulder CJ. S1124 Performance of an Integrated Risk Profile for Selection of High Risk Individuals for Colorectal Cancer Screening Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)60840-2  0.338
2010 Turenhout STv, Oort FA, Coupe VM, Hulst RWvd, Wesdorp EC, Larbi IB, Kanis SL, Hengel Ev, Bouman AA, Meijer GA, Mulder CJ. S1123 Double Versus Single Sampling of Fecal Immunochemical Tests for Colorectal Cancer Screening; Added Value or Added Costs? Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)60839-6  0.325
2010 Voorham QJM, Carvalho B, Spiertz AJ, Grieken NCTv, Grabsch HI, Rembacken B, Kliment M, Wiel MAvd, Ylstra B, Bruïne APd, Mulder CJJ, Engeland Mv, Meijer GA. DNA copy number alterations in flat colorectal adenomas Cancer Genetics and Cytogenetics. 203: 71. DOI: 10.1016/J.Cancergencyto.2010.07.059  0.328
2010 Haan JC, Buffart TE, Wiel MAvd, Carvalho B, Postma C, Eijk PP, Grieken NCTv, Nagtegaal ID, Mulder CJJ, Maude K, Howdle P, Quirke P, Grabsch H, Meijer GA, Ylstra B. Small bowel adenocarcinomas are more similar to colorectal than gastric cancer according to their chromosomal copy number profile Cancer Genetics and Cytogenetics. 203: 56. DOI: 10.1016/J.Cancergencyto.2010.07.029  0.408
2010 Weger VAd, Hooijberg E, Meijer GA, Euler Z, Tinteren Hv. Active Specific Immunotherapy, given as adjuvant treatment, improves survival of patients with microsatellite stable colorectal tumors, but not of patients with microsatellite instable colorectal tumors Cancer Genetics and Cytogenetics. 203: 52. DOI: 10.1016/J.Cancergencyto.2010.07.020  0.358
2009 Belien JAM, Buffart TE, Gill AJ, Broeckaert MAM, Quirke P, Meijer GA, Grabsch HI. Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival. British Journal of Cancer. 101: 1011-1018. PMID 19738619 DOI: 10.1038/Sj.Bjc.6605266  0.358
2009 Buffart TE, Grieken NCTv, Tijssen M, Coffa J, Ylstra B, Grabsch HI, Velde CJHvd, Carvalho B, Meijer GA. High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers Virchows Archiv. 455: 213-223. PMID 19697059 DOI: 10.1007/S00428-009-0814-Y  0.357
2009 Kim MS, Louwagie J, Carvalho B, Terhaar Sive Droste JS, Park HL, Chae YK, Yamashita K, Liu J, Ostrow KL, Ling S, Guerrero-Preston R, Demokan S, Yalniz Z, Dalay N, Meijer GA, et al. Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer. Plos One. 4: e6555. PMID 19662090 DOI: 10.1371/Journal.Pone.0006555  0.391
2009 Buffart TE, Tijssen M, El-Bchiri J, Duval A, Wiel MAvd, Ylstra B, Meijer GA, Carvalho B. NMD inhibition fails to identify tumour suppressor genes in microsatellite stable gastric cancer cell lines. Bmc Medical Genomics. 2: 39-39. PMID 19563644 DOI: 10.1186/1755-8794-2-39  0.403
2009 Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, ... Meijer GA, et al. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. Journal of the National Cancer Institute. 101: 916-27. PMID 19535783 DOI: 10.1093/Jnci/Djp131  0.38
2009 Hellebrekers DM, Lentjes MH, van den Bosch SM, Melotte V, Wouters KA, Daenen KL, Smits KM, Akiyama Y, Yuasa Y, Sanduleanu S, Khalid-de Bakker CA, Jonkers D, Weijenberg MP, Louwagie J, van Criekinge W, ... ... Meijer GA, et al. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3990-7. PMID 19509152 DOI: 10.1158/1078-0432.Ccr-09-0055  0.418
2009 Glöckner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, Chan TA, Kleeberger W, de Bruïne AP, Smits KM, Khalid-de Bakker CA, Jonkers DM, Stockbrügger RW, Meijer GA, Oort FA, et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Research. 69: 4691-9. PMID 19435926 DOI: 10.1158/0008-5472.Can-08-0142  0.391
2009 Derks S, Bosch LJ, Niessen HE, Moerkerk PT, van den Bosch SM, Carvalho B, Mongera S, Voncken JW, Meijer GA, de Bruïne AP, Herman JG, van Engeland M. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. Carcinogenesis. 30: 1041-8. PMID 19329758 DOI: 10.1093/Carcin/Bgp073  0.376
2009 Terhaar Sive Droste JS, Craanen ME, van der Hulst RW, Bartelsman JF, Bezemer DP, Cappendijk KR, Meijer GA, Morsink LM, Snel P, Tuynman HA, van Wanrooy RL, Wesdorp EI, Mulder CJ. Colonoscopic yield of colorectal neoplasia in daily clinical practice. World Journal of Gastroenterology. 15: 1085-92. PMID 19266601 DOI: 10.3748/Wjg.15.1085  0.312
2009 Postma C, Koopman M, Buffart TE, Eijk PP, Carvalho B, Peters GJ, Ylstra B, Krieken JHJMv, Punt CJA, Meijer GA. DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer Annals of Oncology. 20: 1048-1056. PMID 19150955 DOI: 10.1093/Annonc/Mdn738  0.399
2009 Wilting SM, Steenbergen RDM, Tijssen M, Wieringen WNv, Helmerhorst TJM, Kemenade FJv, Bleeker MCG, Wiel MAvd, Carvalho B, Meijer GA, Ylstra B, Meijer CJLM, Snijders PJF. Chromosomal Signatures of a Subset of High-Grade Premalignant Cervical Lesions Closely Resemble Invasive Carcinomas Cancer Research. 69: 647-655. PMID 19147580 DOI: 10.1158/0008-5472.Can-08-2478  0.348
2009 Oudejans JJ, van Wieringen WN, Smeets SJ, Tijssen M, Vosse SJ, Meijer CJ, Meijer GA, van de Wiel MA, Ylstra B. Identification of genes putatively involved in the pathogenesis of diffuse large B-cell lymphomas by integrative genomics. Genes, Chromosomes & Cancer. 48: 250-60. PMID 19051311 DOI: 10.1002/Gcc.20632  0.327
2009 Ruiz MIG, Floor K, Steinberg SM, Grünberg K, Thunnissen FBJM, Belien JAM, Meijer GA, Peters GJ, Smit EF, Rodriguez JA, Giaccone G. Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients. British Journal of Cancer. 100: 145-152. PMID 19050706 DOI: 10.1038/Sj.Bjc.6604781  0.34
2009 Vékony H, Röser K, Löning T, Ylstra B, Meijer GA, van Wieringen WN, van de Wiel MA, Carvalho B, Kok K, Leemans CR, van der Waal I, Bloemena E. Copy number gain at 8q12.1-q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas. Genes, Chromosomes & Cancer. 48: 202-12. PMID 19009612 DOI: 10.1002/Gcc.20631  0.335
2009 Carvalho B, Postma C, Mongera S, Hopmans E, Diskin S, Van De Wiel MA, Van Criekinge W, Thas O, Matthäi A, Cuesta MA, Droste JSTS, Craanen M, Schröck E, Ylstra B, Meijer GA. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression Gut. 58: 79-89. PMID 18829976 DOI: 10.1136/Gut.2007.143065  0.417
2009 Vékony H, Leemans CR, Ylstra B, Meijer GA, van der Waal I, Bloemena E. Salivary gland carcinosarcoma: Oligonucleotide array CGH reveals similar genomic profiles in epithelial and mesenchymal components Oral Oncology. 45: 259-265. PMID 18693132 DOI: 10.1016/J.Oraloncology.2008.05.009  0.343
2009 Bosch LJ, Neerincx M, Oort FA, Mongera S, Masclee A, Jonkers D, Bakker CK, Bierau K, Louwagie J, Criekinge Wv, Bruine APd, Engeland Mv, Mulder CJ, Carvalho B, Meijer GA. W1874 Promoter Hypermethylation of PHACTR3, a Potential New Biomarker for Colorectal Cancer Detection Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)63433-8  0.386
2009 Jonge PJd, Blankenstein Mv, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. T2047 Risk of Colorectal Cancer in Patients with Barrett's Esophagus: A Dutch Population-Based Study Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)62893-6  0.352
2009 Oort FA, Droste JSTs, Hulst RWvd, Heukelem Hv, Loffeld RJ, Wesdorp EC, Larbi IB, Kanis SL, Neerincx M, Räkers M, Coupe VM, Meijer GA, Mulder CJ. T2021 Higher Cut Off Values for Fit in CRC-Screening: Less Colonoscopies, Same Detection Rates for Curable Cancers Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)62867-5  0.397
2009 Oort FA, Droste JSTs, Hulst RWvd, Heukelem Hv, Loffeld RJ, Wesdorp EC, Voorham QJ, Meijer GA, Mulder CJ. 712 Flat Colonic Neoplasia Are Left Undetected By Fecal Immunochemical Tests (FIT) and Will Be Missed in Colorectal Cancer Screening Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)60507-2  0.347
2009 Oort FA, Hulst RWvd, Droste JSTs, Heukelem Hv, Loffeld RJ, Wesdorp EC, Duijkers R, Ooteman R, Valdehueza ZD, Wentink MQ, Coupe VM, Meijer GA, Mulder CJ. 601 Advanced Neoplasia of the Left Hemicolon Are Better Detected By Fit Than Right Sided Lesions Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)60436-4  0.415
2008 Buffart TE, Overmeer RM, Steenbergen RDM, Tijssen M, Grieken NCTv, Snijders PJF, Grabsch HI, Velde CJHvd, Carvalho B, Meijer GA. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. British Journal of Cancer. 99: 1802-1807. PMID 19002170 DOI: 10.1038/Sj.Bjc.6604777  0.38
2008 Capelle LG, de Vries AC, Looman CW, Casparie MK, Boot H, Meijer GA, Kuipers EJ. Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. European Journal of Cancer (Oxford, England : 1990). 44: 2470-6. PMID 18707866 DOI: 10.1016/J.Ejca.2008.07.005  0.308
2008 Bremmer JF, Braakhuis BJ, Brink A, Broeckaert MA, Beliën JA, Meijer GA, Kuik DJ, Leemans CR, Bloemena E, van der Waal I, Brakenhoff RH. Comparative evaluation of genetic assays to identify oral pre-cancerous fields. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 37: 599-606. PMID 18705641 DOI: 10.1111/J.1600-0714.2008.00682.X  0.369
2008 Buffart TE, Israeli D, Tijssen M, Vosse SJ, Mršić A, Meijer GA, Ylstra B. Across array comparative genomic hybridization: a strategy to reduce reference channel hybridizations Genes, Chromosomes and Cancer. 47: 994-1004. PMID 18663753 DOI: 10.1002/Gcc.20605  0.321
2008 Wilting SM, Wilde Jd, Meijer CJLM, Berkhof J, Yi Y, Wieringen WNv, Braakhuis BJM, Meijer GA, Ylstra B, Snijders PJF, Steenbergen RDM. Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer. Genes, Chromosomes and Cancer. 47: 890-905. PMID 18618715 DOI: 10.1002/Gcc.20590  0.332
2008 Coffa J, van de Wiel MA, Diosdado B, Carvalho B, Schouten J, Meijer GA. MLPAnalyzer: data analysis tool for reliable automated normalization of MLPA fragment data. Cellular Oncology : the Official Journal of the International Society For Cellular Oncology. 30: 323-35. PMID 18607067 DOI: 10.3233/Clo-2008-0428  0.308
2008 Ganesan K, Ivanova T, Wu Y, Rajasegaran V, Wu J, Lee MH, Yu K, Rha SY, Chung HC, Ylstra B, Meijer G, Lian KO, Grabsch H, Tan P. Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene. Cancer Research. 68: 4277-86. PMID 18519687 DOI: 10.1158/0008-5472.Can-07-6517  0.352
2008 Jimeno A, Aik CT, Coffa J, Rajeshkumar NV, Kulesza P, Rubio-Viqueira B, Wheelhouse J, Diosdado B, Messersmith WA, Iacobuzio-Donahue C, Maitra A, Varella-Garcia M, Hirsch FR, Meijer GA, Hidalgo M. Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer Cancer Research. 68: 2841-2849. PMID 18413752 DOI: 10.1158/0008-5472.Can-07-5200  0.318
2008 de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, Kuipers EJ. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 134: 945-52. PMID 18395075 DOI: 10.1053/J.Gastro.2008.01.071  0.352
2008 Ruiz MIG, Floor K, Roepman P, Rodriguez JA, Meijer GA, Mooi WJ, Jassem E, Niklinski J, Muley T, Zandwijk Nv, Smit EF, Beebe K, Neckers L, Ylstra B, Giaccone G. Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target. Plos One. 3. PMID 18320023 DOI: 10.1371/Journal.Pone.0001722  0.388
2008 Costa JL, Meijer G, Ylstra B, Caldas C. Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies. Seminars in Radiation Oncology. 18: 98-104. PMID 18314064 DOI: 10.1016/J.Semradonc.2007.10.005  0.398
2008 Derks S, Postma C, Carvalho B, van den Bosch SM, Moerkerk PT, Herman JG, Weijenberg MP, de Bruïne AP, Meijer GA, van Engeland M. Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations. Carcinogenesis. 29: 434-9. PMID 18048385 DOI: 10.1093/Carcin/Bgm270  0.345
2008 Snijders AM, Hermsen MA, Baughman J, Buffart TE, Huey B, Gajduskova P, Roydasgupta R, Tokuyasu T, Meijer GA, Fridlyand J, Albertson DG. Acquired genomic aberrations associated with methotrexate resistance vary with background genomic instability. Genes, Chromosomes & Cancer. 47: 71-83. PMID 17943968 DOI: 10.1002/Gcc.20509  0.303
2007 Fijneman RJA, Carvalho B, Postma C, Mongera S, Hinsbergh VWMv, Meijer GA. Loss of 1p36, gain of 8q24, and loss of 9q34 are associated with stroma percentage of colorectal cancer. Cancer Letters. 258: 223-229. PMID 17977645 DOI: 10.1016/J.Canlet.2007.09.013  0.416
2007 Buffart TE, Carvalho B, Mons T, Reis RMV, Moutinho C, Silva P, Grieken NCTv, Vieth M, Stolte M, Velde CJHvd, Schrock E, Matthaei A, Ylstra B, Carneiro F, Meijer GA. DNA copy number profiles of gastric cancer precursor lesions Bmc Genomics. 8: 345-345. PMID 17908304 DOI: 10.1186/1471-2164-8-345  0.355
2007 De Vries AC, Meijer GA, Looman CWN, Casparie MK, Hansen BE, Van Grieken NCT, Kuipers EJ. Epidemiological trends of pre-malignant gastric lesions: A long-term nationwide study in the Netherlands Gut. 56: 1665-1670. PMID 17698860 DOI: 10.1136/Gut.2007.127167  0.311
2007 Buffart TE, Tijssen M, Krugers T, Carvalho B, Smeets SJ, Brakenhoff RH, Grabsch H, Meijer GA, Sadowski HB, Ylstra B. DNA quality assessment for array CGH by isothermal whole genome amplification. Cellular Oncology : the Official Journal of the International Society For Cellular Oncology. 29: 351-9. PMID 17641418 DOI: 10.1155/2007/709290  0.326
2007 Vékony H, Ylstra B, Wilting SM, Meijer GA, Wiel MAvd, Leemans CR, Waal Ivd, Bloemena E. DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma. Clinical Cancer Research. 13: 3133-3139. PMID 17545515 DOI: 10.1158/1078-0432.Ccr-06-2555  0.334
2007 Mol AJM, Geldof AA, Meijer GA, Poel HGvd, Moorselaar RJAv. New experimental markers for early detection of high-risk prostate cancer: role of cell-cell adhesion and cell migration. Journal of Cancer Research and Clinical Oncology. 133: 687-695. PMID 17520286 DOI: 10.1007/S00432-007-0235-8  0.345
2007 Postma C, Terwischa S, Hermsen MAJA, Sijp JRMvd, Meijer GA. Gain of chromosome 20q is an indicator of poor prognosis in colorectal cancer. Analytical Cellular Pathology. 29: 73-75. PMID 17429145 DOI: 10.1155/2007/137592  0.398
2007 Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, Meijer GA. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cellular Oncology : the Official Journal of the International Society For Cellular Oncology. 29: 19-24. PMID 17429138 DOI: 10.1155/2007/971816  0.324
2007 Saeland E, Vliet SJv, Bäckström M, Berg VCMvd, Geijtenbeek TBH, Meijer GA, Kooyk Yv. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma Cancer Immunology, Immunotherapy. 56: 1225-1236. PMID 17195076 DOI: 10.1007/S00262-006-0274-Z  0.31
2007 Buffart T, Carvalho B, Hopmans E, Brehm V, Kranenbarg EK, Schaaij-Visser T, Eijk P, Grieken Nv, Ylstra B, Velde Cvd, Meijer G. Gastric cancers in young and elderly patients show different genomic profiles. The Journal of Pathology. 211: 45-51. PMID 17117405 DOI: 10.1002/Path.2085  0.39
2007 Jong K, Marchiori E, van der Vaart A, Chin SF, Carvalho B, Tijssen M, Eijk PP, van den Ijssel P, Grabsch H, Quirke P, Oudejans JJ, Meijer GA, Caldas C, Ylstra B. Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors. Oncogene. 26: 1499-506. PMID 16936777 DOI: 10.1038/Sj.Onc.1209919  0.349
2007 Ruiz MIG, Cruijsen Hv, Smit EF, Grünberg K, Meijer GA, Rodriguez JA, Ylstra B, Giaccone G. Genetic Heterogeneity in Patients with Multiple Neoplastic Lung Lesions: A Report of Three Cases Journal of Thoracic Oncology. 2: 12-21. DOI: 10.1016/S1556-0864(15)30012-5  0.33
2006 Carvalho B, Buffart TE, Reis RM, Mons T, Moutinho C, Silva P, Grieken NCTV, Grabsch H, Velde CJHVD, Ylstra B, Meijer GA, Carneiro F. Mixed gastric carcinomas show similar chromosomal aberrations in both their diffuse and glandular components Cellular Oncology. 28: 283-294. PMID 17167181 DOI: 10.1155/2006/650620  0.353
2006 Derks S, Postma C, Moerkerk PT, van den Bosch SM, Carvalho B, Hermsen MA, Giaretti W, Herman JG, Weijenberg MP, de Bruïne AP, Meijer GA, van Engeland M. Promoter methylation precedes chromosomal alterations in colorectal cancer development. Cellular Oncology : the Official Journal of the International Society For Cellular Oncology. 28: 247-57. PMID 17167178 DOI: 10.1155/2006/846251  0.404
2006 Winnepenninckx V, Debiec-Rychter M, Beliën JAM, Fiten P, Michiels S, Lazar V, Opdenakker G, Meijer GA, Spatz A, Oord JJvd. Expression and possible role of hPTTG1/securin in cutaneous malignant melanoma. Modern Pathology. 19: 1170-1180. PMID 16799481 DOI: 10.1038/Modpathol.3800627  0.318
2006 Janmaat ML, Gallegos-Ruiz MI, Rodriguez JA, Meijer GA, Vervenne WL, Richel DJ, Van Groeningen C, Giaccone G. Predictive factors for outcome in a phase II study of gefitinib in second-line treatment of advanced esophageal cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 1612-9. PMID 16575012 DOI: 10.1200/Jco.2005.03.4900  0.342
2006 Wilting SM, Snijders PJ, Meijer GA, Ylstra B, van den Ijssel PR, Snijders AM, Albertson DG, Coffa J, Schouten JP, van de Wiel MA, Meijer CJ, Steenbergen RD. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. The Journal of Pathology. 209: 220-30. PMID 16538612 DOI: 10.1002/Path.1966  0.33
2006 Carvalho B, Postma C, Mongera S, Hermsen M, Ylstra B, Meijer G. Tumour progression in colorectal cancer: array-CGH analysis of the 8q22 q23, 13q21-q31 and 20q amplicons European Journal of Gastroenterology & Hepatology. 18. DOI: 10.1097/00042737-200601000-00117  0.312
2006 Buffart T, Carvalho B, Hopmans E, Brehm V, Kranenbarg EK, Visser B, Ylstra B, Velde Cvd, Meijer G. Gastric cancers in young and old patients have different genomic profiles European Journal of Gastroenterology & Hepatology. 18. DOI: 10.1097/00042737-200601000-00039  0.371
2006 Westerterp M, Sloof GW, Hoekstra OS, Kate FJWt, Meijer GA, Reitsma JB, Boellaard R, Lanschot JJBv, Molthoff CFM. 18FDG uptake in esophageal cancer: linking biology and outcome Journal of Clinical Gastroenterology. 40. DOI: 10.1097/00004836-200609001-00011  0.324
2005 Meijer GA. Chromosomes and Cancer, Boveri Revisited Analytical Cellular Pathology. 27: 273-275. PMID 16373960 DOI: 10.1155/2005/712434  0.378
2005 van de Wiel MA, Costa JL, Smid K, Oudejans CB, Bergman AM, Meijer GA, Peters GJ, Ylstra B. Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomal aberrations. Cancer Research. 65: 10208-13. PMID 16288008 DOI: 10.1158/0008-5472.Can-05-0760  0.338
2005 Hermsen MAJA, Tijssen M, Acero IH, Meijer GA, Ylstra B, Toral JF. High resolution microarray CGH and MLPA analysis for improved genotype/phenotype evaluation of two childhood genetic disorder cases: ring chromosome 19 and partial duplication 2q. European Journal of Medical Genetics. 48: 310-318. PMID 16179226 DOI: 10.1016/J.Ejmg.2005.04.009  0.314
2005 Hermsen M, Guervós MA, Meijer G, Diest Pv, Nieto CS, Marcos CA, Sampedro A. Chromosomal changes in relation to clinical outcome in larynx and pharynx squamous cell carcinoma. Cellular Oncology. 27: 191-198. PMID 16037640 DOI: 10.1155/2005/407216  0.334
2005 Gisbergen KPJMv, Aarnoudse CA, Meijer GA, Geijtenbeek TBH, Kooyk Yv. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Research. 65: 5935-5944. PMID 15994972 DOI: 10.1158/0008-5472.Can-04-4140  0.321
2005 Buffart TE, Coffa J, Hermsen MAJA, Carvalho B, Sijp JRMvd, Ylstra B, Pals G, Schouten JP, Meijer GA. DNA copy number changes at 8q11-24 in metastasized colorectal cancer. Cellular Oncology. 27: 57-65. PMID 15750208 DOI: 10.1155/2005/401607  0.427
2005 Visser Md, Ballegooijen Mv, Bloemers SM, Deventer SJHv, Jansen JBMJ, Jespersen J, Kluft C, Meijer GA, Stoker J, Valk GAd, Verweij MF, Vlems FA. Report on the Dutch consensus development meeting for implementation and further development of population screening for colorectal cancer based on FOBT. Cellular Oncology. 27: 17-29. PMID 15750204 DOI: 10.1155/2005/260692  0.325
2005 Postma C, Hermsen MAJA, Coffa J, Baak JPA, Mueller JD, Mueller E, Bethke B, Schouten JP, Stolte M, Meijer GA. Chromosomal instability in flat adenomas and carcinomas of the colon Journal of Pathology. 205: 514-521. PMID 15685687 DOI: 10.1002/Path.1733  0.37
2005 Carvalho B, Postma C, Mongera S, Ylstra B, Meijer GA. P52: Microarray-CGH analysis of the 8q22–q23, 13q21–q31 and 20q amplicons associated with colorectal cancer progression European Journal of Medical Genetics. 48: 514-515. DOI: 10.1016/J.Ejmg.2005.10.091  0.409
2004 Weiss MM, Kuipers EJ, Postma C, Snijders AM, Pinkel D, Meuwissen SG, Albertson D, Meijer GA. Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cellular Oncology : the Official Journal of the International Society For Cellular Oncology. 26: 307-17. PMID 15623941 DOI: 10.1155/2004/454238  0.356
2004 Oostlander A, Meijer G, Ylstra B. Microarray-based comparative genomic hybridization and its applications in human genetics. Clinical Genetics. 66: 488-495. PMID 15521975 DOI: 10.1111/J.1399-0004.2004.00322.X  0.319
2004 Carvalho B, Ouwerkerk E, Meijer GA, Ylstra B. High resolution microarray comparative genomic hybridisation analysis using spotted oligonucleotides. Journal of Clinical Pathology. 57: 644-646. PMID 15166273 DOI: 10.1136/Jcp.2003.013029  0.311
2003 Bos R, Diest PJv, Groep Pvd, Greijer AE, Hermsen MAJA, Heijnen I, Meijer GA, Baak JPA, Pinedo HM, Wall Evd, Shvarts A. Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1α (HIF-1α) Oncogene. 22: 8948-8951. PMID 14654791 DOI: 10.1038/Sj.Onc.1206995  0.322
2003 Weiss MM, Kuipers EJ, Postma C, Snijders AM, Stolte M, Vieth M, Pinkel D, Meuwissen SG, Albertson D, Meijer GA. Genome wide array comparative genomic hybridisation analysis of premalignant lesions of the stomach. Molecular Pathology : Mp. 56: 293-8. PMID 14514924 DOI: 10.1136/Mp.56.5.293  0.41
2003 Weiss MM, Snijders AM, Kuipers EJ, Ylstra B, Pinkel D, Meuwissen SG, van Diest PJ, Albertson DG, Meijer GA. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization. The Journal of Pathology. 200: 320-6. PMID 12845628 DOI: 10.1002/Path.1359  0.33
2003 Weiss MM, Kuipers EJ, Meuwissen SG, van Diest PJ, Meijer GA. Comparative genomic hybridisation as a supportive tool in diagnostic pathology. Journal of Clinical Pathology. 56: 522-7. PMID 12835298 DOI: 10.1136/Jcp.56.7.522  0.34
2003 Ruivenkamp C, Hermsen M, Postma C, Klous A, Baak J, Meijer G, Demant P. LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21. Oncogene. 22: 3472-4. PMID 12776199 DOI: 10.1038/Sj.Onc.1206246  0.433
2003 Baak JPA, Path FRC, Hermsen MAJA, Meijer G, Schmidt J, Janssen EAM. Genomics and proteomics in cancer. European Journal of Cancer. 39: 1199-1215. PMID 12763207 DOI: 10.1016/S0959-8049(03)00265-X  0.379
2003 Weiss MM, Kuipers EJ, Postma C, Snijders AM, Siccama I, Pinkel D, Westerga J, Meuwissen SG, Albertson DG, Meijer GA. Genomic profiling of gastric cancer predicts lymph node status and survival. Oncogene. 22: 1872-9. PMID 12660823 DOI: 10.1038/Sj.Onc.1206350  0.354
2003 Weiss MM, Kuipers EJ, Hermsen MA, van Grieken NC, Offerhaus J, Baak JP, Meuwissen SG, Meijer GA. Barrett's adenocarcinomas resemble adenocarcinomas of the gastric cardia in terms of chromosomal copy number changes, but relate to squamous cell carcinomas of the distal oesophagus with respect to the presence of high-level amplifications. The Journal of Pathology. 199: 157-65. PMID 12533828 DOI: 10.1002/Path.1260  0.347
2003 van der Wal JE, Hermsen MA, Gille HJ, Schouten-Van Meeteren NY, Moll AC, Imhof SM, Meijer GA, Baak JP, van der Valk P. Comparative genomic hybridisation divides retinoblastomas into a high and a low level chromosomal instability group. Journal of Clinical Pathology. 56: 26-30. PMID 12499428 DOI: 10.1136/Jcp.56.1.26  0.354
2003 Weiss MM, Kuipers E, Postma C, Snijders AM, Siccama I, Pinkel D, Westerga J, Meuwissen S, Albertson D, Meijer G. Genomic profling of gastric cancer predicts lymph node status and survival Gastroenterology. 124. DOI: 10.1016/S0016-5085(03)80927-7  0.321
2003 Jong K, Marchiori E, Vaart Avd, Ylstra B, Weiss M, Meijer G. Chromosomal breakpoint detection in human cancer Lecture Notes in Computer Science. 54-65. DOI: 10.1007/3-540-36605-9_6  0.391
2002 Menko FH, Kaspers GL, Meijer GA, Claes K, Hagen JMv, Gille JJP. A homozygous MSH6 mutation in a child with café-au-lait spots, oligodendroglioma and rectal cancer. Familial Cancer. 3: 123-127. PMID 15340263 DOI: 10.1023/B:Fame.0000039893.19289.18  0.357
2002 Weiss MM, Hermsen MA, Meijer GA, van Diest PJ. Comparative genomic hybridization in cancer investigations. Methods in Molecular Biology (Clifton, N.J.). 204: 369-78. PMID 12397810 DOI: 10.1385/1-59259-300-3:369  0.379
2002 Gille JJP, Hogervorst FBL, Pals G, Wijnen JT, Schooten RJv, Dommering CJ, Meijer GA, Craanen ME, Nederlof PM, Jong Dd, McElgunn CJ, Schouten JP, Menko FH. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach British Journal of Cancer. 87: 892-897. PMID 12373605 DOI: 10.1038/Sj.Bjc.6600565  0.378
2002 Hermsen M, Postma C, Baak J, Weiss M, Rapallo A, Sciutto A, Roemen G, Arends J, Williams R, Giaretti W, Goeij Ad, Meijer G. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability Gastroenterology. 123: 1109-1119. PMID 12360473 DOI: 10.1053/Gast.2002.36051  0.401
2001 Meijer GA, Diest PJv, Brugghe J, Baak JPA. Quantitative immunohistochemistry of estrogen and progesterone receptor positivity in ovarian tumors : a rapid and reliable stereological approach. Methods in Molecular Medicine. 39: 535-544. PMID 21340810 DOI: 10.1385/1-59259-071-3:535  0.313
2001 Hermsen MAJA, Xie Y, Rooimans MA, Meijer GA, Baak JPA, Plukker JTM, Arwert F, Joenje H. Cytogenetic characteristics of oral squamous cell carcinomas in Fanconi anemia. Familial Cancer. 1: 39-43. PMID 14574014 DOI: 10.1023/A:1011528310346  0.391
2001 Zweemer RP, Ryan A, Snijders AM, Hermsen MAJA, Meijer GA, Beller U, Menko FH, Jacobs IJ, Baak JPA, Verheijen RHM, Kenemans P, Diest PJv. Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma. Laboratory Investigation. 81: 1363-1370. PMID 11598149 DOI: 10.1038/Labinvest.3780350  0.373
2001 Hausen AZ, Grieken NCTV, Meijer GA, Hermsen MAJA, Bloemena E, Meuwissen SGM, Baak JPA, Meijer CJLM, Kuipers EJ, Brule AJCVD. Distinct chromosomal aberrations in Epstein-Barr virus-carrying gastric carcinomas tested by comparative genomic hybridization. Gastroenterology. 121: 612-618. PMID 11522745 DOI: 10.1053/Gast.2001.27200  0.341
2001 Hermsen M, Guervós MA, Meijer G, Baak J, Diest Pv, Marcos CA, Sampedro A. New chromosomal regions with high-level amplifications in squamous cell carcinomas of the larynx and pharynx, identified by comparative genomic hybridization. The Journal of Pathology. 194: 177-182. PMID 11400146 DOI: 10.1002/Path.862  0.325
2001 Weiss MM, Snijders A, Meijer GA, Meuwissen SG, Baak JP, Pinkel D, Albertson DG, Kuipers EJ. Microarray comparative genomic hybridization reveals a narrow gain at 20q13 in human gastric carcinomas Gastroenterology. 120. DOI: 10.1016/S0016-5085(08)81480-1  0.321
2000 van Grieken NC, Weiss MM, Meijer GA, Hermsen MA, Scholte GH, Lindeman J, Craanen ME, Bloemena E, Meuwissen SG, Baak JP, Kuipers EJ. Helicobacter pylori-related and -non-related gastric cancers do not differ with respect to chromosomal aberrations. The Journal of Pathology. 192: 301-6. PMID 11054712 DOI: 10.1002/1096-9896(2000)9999:9999<::Aid-Path697>3.0.Co;2-F  0.357
2000 Giaretti W, Macciocu B, Geido E, Hermsen MAJA, Postma C, Baak JPA, Williams RA, Meijer GA. Intratumor heterogeneity of k-ras and p53 mutations among human colorectal adenomas containing early cancer. Analytical Cellular Pathology. 21: 49-57. DOI: 10.1155/2001/905923  0.381
1999 Craanen ME, Blok P, Offerhaus GJA, Meijer GA, Dekker W, Kuipers EJ, Meuwissen SGM. p21Waf1/Cip1 expression and the p53/MDM2 feedback loop in gastric carcinogenesis The Journal of Pathology. 189: 481-486. PMID 10629547 DOI: 10.1002/(Sici)1096-9896(199912)189:4<481::Aid-Path482>3.0.Co;2-U  0.309
1999 Meijer GA, Schroeijers AB, Flens MJ, Meuwissen SGM, Valk PVD, Baak JPA, Scheper RJ. Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis. Journal of Clinical Pathology. 52: 450-454. PMID 10562814 DOI: 10.1136/Jcp.52.6.450  0.33
1999 Torenbeek R, Hermsen MAJA, Meijer GA, Baak JPA, Meijer CJLM. Analysis by comparative genomic hybridization of epithelial and spindle cell components in sarcomatoid carcinoma and carcinosarcoma: histogenetic aspects The Journal of Pathology. 189: 338-343. PMID 10547594 DOI: 10.1002/(Sici)1096-9896(199911)189:3<338::Aid-Path429>3.0.Co;2-Q  0.315
1998 Hermsen MA, Baak JP, Meijer GA, Weiss JM, Walboomers JW, Snijders PJ, van Diest PJ. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors. The Journal of Pathology. 186: 356-62. PMID 10209483 DOI: 10.1002/(Sici)1096-9896(199812)186:4<356::Aid-Path196>3.0.Co;2-Z  0.344
1998 Meijer GA, Hermsen MAJA, Baak JPA, Diest PJV, Meuwissen SGM, Beliën JAM, Hoovers JMN, Joenje H, Snijders PJF, Walboomers JMM. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. Journal of Clinical Pathology. 51: 901-909. PMID 10070331 DOI: 10.1136/Jcp.51.12.901  0.344
1998 Lagendijk JH, Mullink H, Diest PJV, Meijer GA, Meijer CJLM. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Human Pathology. 29: 491-497. PMID 9596273 DOI: 10.1016/S0046-8177(98)90065-X  0.309
1998 Meijer GA, Baak JPA, Talbot IC, Atkin WS, Meuwissen SGM. Predicting the risk of metachronous colorectal cancer in patients with rectosigmoid adenomas using quantitative pathological features. A case–control study The Journal of Pathology. 184: 63-70. PMID 9582529 DOI: 10.1002/(Sici)1096-9896(199801)184:1<63::Aid-Path974>3.0.Co;2-D  0.415
1998 Grieken NCTv, Hermsen MAJA, Meijer GA, Craanen ME, Weiss MM, Bloemena E, Baak JPA, Meuwissen SGM, Kuipers EJ. Chromosomal aberrations in gastric cancer analysed by comparative genomic hybridization European Journal of Gastroenterology & Hepatology. 10. DOI: 10.1097/00042737-199812000-00251  0.38
1998 Hermsen MAA, Weis MM, Meijer GA, Weiss I, Snijders PJF, Walboomers JMM, Meuwissen SGM, Baak JPA. Chromosmal aberrations detected by comparative genomic hybridization in colorectal adenomas from patients with multiple tumors European Journal of Gastroenterology & Hepatology. 10. DOI: 10.1097/00042737-199812000-00124  0.367
1998 Meijer GA, Hermsen MAJA, Diest PJv, Meuwissen SGM, Joenje H, Hoovers JMN, Snjders PJF, Walboomers JMM, Baak JPA. Comparative genomic hybridization reveals non-random chromosomal aberrations to be associated with progression from colorectal adenoma to carcinoma European Journal of Gastroenterology & Hepatology. 10. DOI: 10.1097/00042737-199812000-00123  0.36
1998 Meijer G, Hermsen M, Diest Pv, Meuwissen S, Hoovers J, Joenje H, Snijders P, Wallboomers J, Baak J. Comparative genomic hybridization reveals non-random chromosomal aberrations to be associated with progression from colorectal adenoma to carcinoma Gastroenterology. 114. DOI: 10.1016/S0016-5085(98)82626-7  0.36
1998 Hermsen M, Weiss M, Meijer G, Weiss I, Snijders P, Walboomers J, Meuwissen S, Baak J. Chromosomal aberrations detected by comparative genomic hybridization in colorectal adenomas from patients with multiple tumors Gastroenterology. 114. DOI: 10.1016/S0016-5085(98)82488-8  0.373
1996 Brinkhuis M, Baak JPA, Meijer GA, Diest PJV, Mogensen O, Bichel P, Neijt JP. Value of quantitative pathological variables as prognostic factors in advanced ovarian carcinoma. Journal of Clinical Pathology. 49: 142-148. PMID 8655681 DOI: 10.1136/Jcp.49.2.142  0.367
1996 Hermsen MAJA, Meijer GA, Baak JPA, Joenje H, Walboomers JJM. Comparative genomic hybridization: A new tool in cancer pathology☆ Human Pathology. 27: 342-349. PMID 8617476 DOI: 10.1016/S0046-8177(96)90106-9  0.348
1995 Brinkhuis M, Meijer GA, Baak JPA. An evaluation of prognostic factors in advanced ovarian cancer European Journal of Obstetrics & Gynecology and Reproductive Biology. 63: 115-124. PMID 8903765 DOI: 10.1016/0301-2115(95)02211-2  0.362
1995 Meijer GA, Baak JPA, Talbot IC, Atkin WS, Meuwissen SGM. Prognostic value of quantitative pathological features in rectosigmoid adenomas of the long-term risk of colorectal cancer: a case control study Netherlands Journal of Medicine. 47. DOI: 10.1016/0300-2977(95)97053-R  0.354
Show low-probability matches.